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INTRODUCTION
1. INTRODUCTION
        1.1 Drug delivery system
In the past few years there has been an exceptional growth in research focused on
drug delivery systems. This tremendous growth in this field is due to the exploration in the
field of medicine and possibilities that these systems offer to biomedicine, such as several
drugs  which  have  been  synthesized  and  thereafter  these  drugs  being  formulated  into
suitable dosage forms for administration using new therapies which in turn improved the
efficacy and safety. This gives a chance of delivering new complex drugs that otherwise
would not have been possible. The improvement of therapeutic responses with continuous
drug release (controlled drug release) patterns rather than pulsatile (conventional dosage
forms). The opportunities that recent advances in material sciences and biotechnology offer
to develop new physical and medical methods of drug delivery have to be well obliged.
There  has  been  an  upward  trend  in  designing  new  dosage  forms  and  also  make  it
biocompatible[1]. However, the real advance has emerged as the development of targeted
delivery in which the drug acts in the target area of the body. For this type of system, site
specific and disease specific drugs need to be used since it is vital to direct the drugs where
they are  specifically  needed[2].  Additionally,  the  sustained  release  in  which  the  drug  is
released over a period of time in a controlled fashion has also been revealed as a milestone
of this type of technology. 
Advances in controlled release drug delivery systems have been largely based on
advances in functional polymers. However, the future of controlled release dosage forms
will  likely  be  heavily  dependent  upon  the  success  of  delivery approaches  in  the  next
millennium will  require interdisciplinary approaches.  Development of controlled release
drug delivery systems requires simultaneous consideration of several factors, such as the
drug  property,  route  of  administration,  nature  of  delivery  vehicle,  mechanism of  drug
release, ability of targeting, and biocompatibility[3].
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1.2 Controlled release oral drug delivery systems 
In  spite  of  rapid  progress  in  our  understanding  of  the  fundamental  biological
processes underlying  many diseases, the progress of  a breakthrough in developing drug
molecules or designing of new pharmaceutical drug delivery dosage forms   in reaching the
site of abnormality and achieve comparable  advances  in the  detection,  diagnosis,  and
mitigation  of  these  diseases is substantially on the back foot. The need for such targeting
mainly arises  from  the  fact that  most therapeutic  agents  do  not  efficiently direct to and
accumulate  in  the desired  sites  due  to  their  nonspecific  distribution  throughout  the
body.  As a result, conventional therapeutic agents are required in high doses[4]. Moreover,
drug  discovery and  development  involves  highly  challenging,  laborious  and  expensive
processes. Unless, a minor change is imparted to an already marketed dosage form all other
new  formulations  need  to  go  through  certain  set  of  clinical  investigation  before  it  is
released in  the market.  This  process  is  highly costly and time consuming but  must  be
understood as inevitable for the safety of the patient. The development process of each new
drug takes an average of 15 years with an estimated cost  of about US $ 0.802 billion.
However, most of the drugs fail to achieve favorable clinical  outcomes  in  the  clinical
phase,  because  they  do  not  have  the  ability  to  reach the target site of action, or  do not
comply with the standards. Thus, the optimization of the drug molecules for achieving a
plasma drug concentration associated with a safe clinical effect is the major challenge in
drug development[2, 3].
Figure 1.1 Strategic tools for drug delivery systems
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  An  effective  approach  to  overcome  this  critical  issue  is the  development  of
controlled  drug  delivery  systems of already available drugs. This  could  increase  patient
compliance  and  therapeutic  efficacy  of  pharmaceutical  agents  through  improved
pharmacokinetics  and  bio  distribution[5].  Therefore,  delivering  drug  at  controlled  rate,
targeted delivery are very attractive ways and being pursued very vigorously.  Although
conventional  drug  delivery  formulations  have  contributed  greatly  to  the  treatment  of
disease,  the  development  of  controlled  delivery  systems  has  escalated[6]. Figure  1.1
illustrates the strategic tools for controlled drug delivery systems.
Controlled  drug  delivery  systems  offer  numerous  advantages  compared  to
conventional   dosage  forms[6,7].   The benefit characteristics of controlled drug delivery
systems are as follows: 
 Controlled delivery of active agent at predetermined rate
 Reduced dosing frequency
 Better patient convenience and compliance
 Reduced GI side effects
 Improved efficacy/safety ratio
 Less fluctuating plasma drug levels
 More uniform drug effect
 Reduction in adverse side effects
 Lesser total dose
In  order to  achieve  most  effective  drug therapy,  it  is  required  to  have  desired
pharmacological  response  at  the  target  without  harmful  side  effect  at  other  sites.  This
requires  the  correct  dose of  drug to  be  absorbed  into the  body  and  transported to the
target[8]. The way in which a drug delivered to the target can have a significant effect on its
efficacy.  Some  drug  molecules  have  an  optimum  concentration  range within  which
maximum  benefit  is  derived,  and  concentrations  above  or  below optimum  range  can
be  toxic  or  yield  no  therapeutic  benefit  at  all  (Figure  1.2) . More  recently,  there  has
been  increasing  interest  in  developing  methods  where  drug release can be controlled
either by an interaction between a “smart” material  and changes  in  its   environment.
Ideally, such systems could determine the timing, duration, dosage, and even location of
drug release[9].
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Figure  1.2 Drug  level  in  the  blood  with  controlled  release  delivery.
(Biopharmaceuitics & pharmacokinetics D M.Brahmankar & Sunil B. Jaiswal)
Novel technologies with improved performance, patient compliance, and enhanced
quality  have  emerged  in  the  recent  past.  Oral  fast-dispersing  dosage  forms,  three-
dimensional Printing (3DP) and electrostatic coating are a few examples of a few existing
technologies  with  the  potential  to  accommodate  various  physico-chemical,
pharmacokinetic  and  pharmacodynamic  characteristics  of  drugs[10]. The  gastrointestinal
tract is complex structure.  A diagram of the gastrointestinal tract, outlining some of the key
structures involved in and key physiological parameters that affect oral drug absorption
(Figure 1.3).  In  order  to  gain an insight  into the numerous factors  that  can potentially
influence the It can be seen from this that the rate and extent of appearance of intact drug in
the systemic circulation depends on a succession of kinetic processes. The slowest step in
this series, which is known as the rate-limiting step, controls the overall rate and extent of
appearance of intact drug in the systemic circulation. The particular rate-limiting step will
vary from drug to drug. For a drug which has a very poor aqueous solubility the rate at
which  it  dissolves  in  the  gastrointestinal  fluids  is  often  the  slowest  step,  and  the
bioavailability of that drug is said to be dissolution-rate limited. In contrast, for a drug that
has a high aqueous solubility its dissolution will be rapid and the rate at which the drug
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crosses  the  gastrointestinal  membrane  may  be  the  rate-limiting  step  (permeability
limited[11].  
Figure  1.3 Diagram  of  the  gastrointestinal  tract,  outlining  some  of  the  key
structures involved in and key physiological parameters that affect oral drug absorption 
Drug delivery has been accomplished by many conventional drug delivery systems.
Oral  drug  delivery  has  been  known  for  decades  as  a  widely  used  route  of  drug
administration. It has been envisaged as different dosage forms and designs. Oral route also
brings with it the ease of administration, high patient compliance, and flexibility in design
of the dosage form. The basic goal of any drug delivery system is to steady state blood,
tissue level of the drug enough to mitigate/cure the disease taking the precaution of not
being toxic to  the body.  The oral  route of  delivery is  by far  the most  popular,  mainly
because it  is natural  and convenient for the patient  and because it  is  relatively easy to
manufacture  oral  dosage  forms.  Oral  dosage  forms  do  not  need  to  be  sterilized,  are
compact,  and can be produced in large quantities by automated machines[11].  Therefore,
foremost requirement of the drug delivery system is to identify orally active candidates that
would provide reproducible and effective plasma concentrations  in vivo[12]. The oral drug
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delivery is the largest and the oldest segment of the total drug delivery market (Figure 1.4)
[13,14] 
Figure 1.4 Current global business scenarios
         1.3 Currently available drug delivery systems[15]
The carrier plays an important role in carrying the drug molecule to the target site. It
acts as a skeleton or a back bone to the drug.  Drug carriers are substances that serve as
mechanisms to improve the delivery and the effectiveness of drugs. Drug carriers are used
in sundry drug delivery systems such as:
 controlled-release technology to prolong in vivo drug actions
 decrease drug metabolism
 reduce drug toxicity
Carriers are also used in designs to increase the effectiveness of drug delivery to the
target  sites  of  pharmacological  actions.  The  listed  drug  carriers  have  different
physicochemical properties which make them suitable for different  drugs.  The common
goal of the carrier is to transport drug molecules to the target site in a controlled manner.
Ideally, they should be biocompatible, not cause any immunogenic or cellular reactions and
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release drug molecule controllably at the target sites without altering its therapeutic effects.
Some of the most popular drug carriers are:
 Liposomes
 Micelle
 Dendrimers
 Polymer
 Carbon nanotubes
 Gold and Iron oxide nano particles
 Titanium dioxide
 Mesoporous Silica nanoparticles
1.3.1. Liposomes 
Liposomes are spherical self-closed structures, composed of curved lipid bilayers,
which enclose part of the surrounding solvent into their interior. The size of a liposome
ranges from some 20 nm up to several micrometers and they may be composed of one or
several concentric membranes, each with a thickness of about 4 nm. Liposomes possess a
lipid bi layer as a result of this it has unique properties such as amphiphilicity, which make
them suitable for drug delivery[16]. A schematic representation of a liposome is shown in
Figure 1.5. The drug molecules can be loaded within the lipid bilayer or in the aqueous core
or at the interface between them. Since the lipid is an essential biomolecule for most living
tissues and has an amphiphilic nature, that is, ability to spontaneously self-assemble into a
variety of microstructures, liposome is used widely as a temperature or pH-sensitive drug
delivery vehicle particularly for cytotoxic anti-cancer drugs[17]. 
Figure 1.5 A schematic representation of a liposomes.
Hydrophobic  drugs,  for  example,  Amphotericin  B,  Taxol  Orannamycin,  can  be
passively incorporated  into  liposomes  with  100% trapping efficiencies.  For  hydrophilic
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drugs, however, active loading is required to get this level of entrapment[18]. Furthermore;
the  drug  encapsulated  in  liposomes  can  be  transported  to  the  target  site  without  rapid
degradation and minimum side effect. Liposomes also have a unique ability to deliver the
entrapped drug into cells by fusion or endocytosis, and therefore, any drug can be loaded
into the liposome regardless of its solubility[19].
1.3.2. Micelles
Micelle  is  an  aggregate  of  amphipathic  molecules  in  water,  with  the
nonpolar portions in the interior  and the polar portions at  the exterior surface,  exposed
to water.  Amphiphilic  molecules  form micelle above a particular concentration which is
called  as  critical  micellar  concentration  (CMC)[20].   Micelles  are  known  to have  an
anisotropic water distribution within their structure, means water concentration decreases
from the surface towards the core of the micelle, with a completely hydrophobic (water-
excluded) core. Hence hydrophobic drugs can be encapsulated/solubilized, into inner core.
Consequently,  the spatial  position of  a  solubilized drug in a micelle will  depend on its
polarity, nonpolar molecules will be solubilized in the micellar core, and substances with
intermediate  polarity will  be  distributed  along  the  surfactant  molecules  in  certain
intermediate positions. Polymeric  micelles  are  generally  more  stable, with  a  remarkably
lowered CMC, and have a slower rate of dissociation, allowing retention of loaded drugs
for a longer period of time and, eventually, achieving higher accumulation of a drug at the
target  site.  Furthermore, polymeric  micelles  have  mesoscopic  size  range  with  a
considerably narrow distribution.  Size  is  certainly  a  crucial  factor  in  determining  their
body disposition, especially when an enhanced permeation retention effect (EPR effect) is
involved. It is also possible to functionalize the shell of the nanoparticles for targeted drug
delivery[21,  22].   This  technology  is  under  clinical  study for  various  applications  some
enlisted bellow in the table.   
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Figure1.6 Schematic  representation  for  the  formation  of  micelle  by  controlled
dialysis of polymer and drug solution (in water miscible solvent)
1.3.3. Dendrimers
Dendrimers have a wide range of application that can be utilised in various areas
such as material science, catalysis and drug delivery. This versatility to target multiple sites
is because of the presence of branched structure which have wide scope as elucidated in
Figure 1.6. Also, due to its distinctive structure, it can selectively host biomolecules and
deliver  them to  the  target  sites.  For  example,  the  most  common  type  of  dendrimer  is
polyamidoamine  dendrimers  which  can  selectively  host  methotrexate[22].  However,  the
toxicity of dendrimers has been of concern. The non-degradable dendrimers produced side
effects  with  repeated  administration.Thus,  the  modification  of  cationic  dendrimers  is
K. M. COLLEGE OF PHARMACY, MADURAI Page 9
INTRODUCTION
essential  to  prevent  its  accumulation  in  the  liver  and  to  inhibit  nonspecific  toxicity.
Polyester–based dendrimers are under  research to  overcome the biocompatibility issues
faced  by these  polyamidoamine;  which  is  done  by bringing  a  change  in  the  chemical
composition[23].
Figure 1.7 A schematic representation of a Dendrimers
1.3.4. Polymers
In addition to the widespread application of polymers in manufacturing different
materials, they are also used in several formulations and devices for drug delivery.  When
developing drug delivery systems, it is important to control how much of the drug is being
released – too much of the drug at once can be harmful to the body, but too little of it may
limit its effectiveness. Delivery of drugs at the optimal dosage for optimal lengths of time
will  make them more effective and more powerful. It  is  with the use of polymers that
manufacturers are able to deliver drugs more and more effectively. Some of the unique
characteristics of polymers that make them versatile in drug delivery systems include :
 wide molecular weight distributions
 variety of visco-elastic properties
 special characteristics associated with phase transitions
 able to contract when heated
 variety of dissolution times
 specialized chemical reactivities
 tolerate a variety of manufacturing methods
Polymeric NPs are colloidal particles with a size range of 10–1000 nm, and they
can  be  spherical,  branched  or  core–shell  structures.  They  have  been  fabricated  using
biodegradable  synthetic  polymers,  such  as  polylactide–polyglycolide  copolymers,
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polyacrylates  and  polycaprolactones,  or  natural  polymers,  such  as  albumin,  gelatin,
alginate, collagen and chitosan. Advances in polymer science and engineering have resulted
in the development of smart  polymer (stimuli-sensitive polymer),  which can change its
physicochemical  properties in response to environmental  signals.  Physical  (temperature,
ultrasound, light, electricity and mechanical stress), chemical (pH and ionic strength) and
biological signals (enzymes and biomolecules) have been used as triggering stimuli. The
versatility of  polymer  sources  and  their  easy combination  make it  possible  to  tune  up
polymer sensitivity in response to a given stimulus within a narrow range, leading to more
accurate and programmable drug delivery.
Polymeric  nanocarriers  can  be  categorized  based  on  three  drug-incorporation
mechanisms. The first includes polymeric carriers that use covalent chemistry for direct
drug  conjugation  (e.g.,  linear  polymers).  The  second  group  includes  hydrophobic
interactions  between drugs and nanocarriers (e.g.,  polymeric micelles from amphiphilic
block copolymers).  Polymeric nanocarriers  in the third  group include hydrogels,  which
offer a water-filled depot for hydrophilic drug encapsulation.
Figure  1.8 Polymeric  micelles  are  used  in  delivering  hydrophobic  drugs  more
effectively. (Diagram courtesy of AS Hoffman, University of Washington, Seattle, WA.)
1.3.5. Carbon nanotubes[25,26]
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Carbon nanotubes (CNTs) are very prevalent in today’s world of medical research
and  are  being  highly  researched  in  the  fields  of  efficient drug  delivery and  biosensing
methods for  disease treatment and health monitoring. Carbon nanotubes  technology has
shown to have the potential to alter drug delivery and biosensing methods for the better,
and thus, carbon nanotubes have recently garnered interest in the field of medicine. They
are low dimensional sp2 carbon nanomaterials,  and their flexibility is produced by their
various  physicochemical  properties  that  can  be  used  in   the  transportation  of  various
therapeutic  agents  such  as  vaccine,  protein,  antibiotics  and  anti-cancer  and  anti-
inflammatory agents . A schematic picture of a CNT is shown in Figure 1.9. However, the
insolubility  of  CNTs  can  pose  health  complications.  For  example,  CNTs  without
functionalisation  can  accumulate  in  the  lungs,  which  leads  to  pulmonary  toxicity  and
inflammation.  This  perniciousness  is  highly  dependent  on  material  preparation  and
administration route of CNTs. As with liposomes and dendrimers, a biocompatible coating
such as PEGlyation can remarkably reduce in vivo toxicity of CNTs.
Figure 1.9 A schematic representation of a carbon nanotubes
1.3.6. Gold and Iron oxide nanoparticles
Gold and iron oxide are widely used in controlled drug release, especially in anti-
cancer  therapy.  They  are  mostly  used  in  combination  with  other  biomolecules.  For
example, magnetic iron oxide provides the core of the particle, while the shell is composed
of  silica,  dextran  or  gold  attached  via  cross-linkers[27].  The  advantage  of  using  gold
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nanoparticle is that it can release drug molecule in a controlled manner by absorbing heat
and increasing kinetic energy to release drug molecules. Similarly,  controlled release of
drug molecule is possible with iron oxide under the influence of an external magnetic field.
This can ultimately reduce dose and systemic absorption of cytotoxic drugs by guiding
them to the target tumour cells[27]. However, in real practice, there are many parameters to
be  considered  such  as  magnetic  properties,  field  strength  and field  geometry,  depth  of
target,  blood  flow,  body  weight  and  vascular  supply.   For  gold  nanoparticles,  the
accumulation and excretion profiles are not well understood, and the accumulation within
bloodstream  can  block  blood  flow.  Also,  the  cost  of  gold  nanomaterials  needs  to  be
considered.  Iron  oxide  needs  surface  functionalization  due  to  poor  solubility[28].  A
schematic picture of a gold and iron oxide nanoparticle is shown in Figure 1.8.
Figure 1.10 A schematic representation of a gold and iron oxide nanoparticles
1.3.7. Titanium dioxide
Micro-  and  nanoporous  titanium dioxide  (TiO2)  film,  applied on  the  surface  of
titanium  implant  using  micro-arc  oxidation  and  anodic  titanium  oxide  treatments,
respectively, has been employed as a container for antibiotic loaded sol-gel derived silica
xerogel.  The  presence  of  micro-  and  nanoporous  TiO2 film enhanced  the  drug-loading
efficiency of sol-gel derived silica xerogel and provided controlled release of antibiotic.
TiO2 is also a potential photosensitiser, which can catalyse DNA damage; the release of
drugs or active molecules can be triggered by ultraviolet light or X-ray radiation. TiO2 is
chemically inert and is ideal for use in chemo-therapy as it can inhibit tumour growth[29].
Recently, the development of ‘smart’ pH-responsive drug delivery vehicle based on TiO2
nanoparticles  for  intelligent  and  enhanced  delivery of  chemotherapeutic  drug  has  been
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attempted. The ‘smart’ TiO2 nanoparticles only release the anti-cancer drug under acidic
pH, that is, in the vicinity of the tumour tissue, and this is a desirable characteristic for
tumour-targeted drug delivery[30].
Figure 1.11 A schematic representation of a titanium dioxide nanoparticle
1.3.8. Mesoporous silica nanoparticles (MSNPs)
  Ordered  mesoporous  materials have been  preferred by  many  researchers  due
to  their  exclusive  properties;  highly  ordered  structure, tunable  pore  size,  high  surface
area   and   good   thermal   stability.   Moreover,   these   mesoporous  materials   have
concerned  for  many  applications  such  as;  sensors,  adsorption,  catalysis  and  ion
exchange. Even though these types of materials have used for many applications, they were
not attracted for drug delivery systems until 2001. Today, intensive researches are ongoing
to  increase  applications  of  ordered  mesoporous  materials  in  controlled  drug  delivery
systems[31].
Mesoporous  materials  also  get  attention  for  drug  delivery  systems  due  to  their
biocompatibility.  Mesoporous materials are biocompatible and nontoxic. Sarah P. Hudson
and her coworkers did some experiments with animals to control the biocompatibility of
mesoporous samples by using both SBA-15 and MCM-41 samples.  They exhibited that
mesoporous  silicate  particles  had  biocompatibility.  Besides,  nontoxic  properties  of
mesoporous  silicates  were  specified[32].  Mesoporous  silica  seems  to  be  ideal   for
encapsulation  of  pharmaceutical  drug,  proteins  and  other  biogenic  molecules  due to
its following properties.
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 An ordered pore network 
 High pore volume 
 High surface area 
 A silanol-containing surface
Due  to  the  presence  of  a  high  concentration  of  silanol  groups  on  the  surface
(Figure 5), silica can  be  functionalized to control pore size and surface properties, which
makes them suitable for controlled drug delivery [33].
Figure  1.12 Nanostructured  mesoporous  silica  matrices  and  a  schematic
representation of the different  steps involved in the performance of MSNPs as stimuli-
responsive drug delivery devices.
Many  of  the  conventional  nano  drug  delivery  systems  (DDS)  (e.g.  liposomes,
micelles, and polymer-based) have reached the later stages of development, and a few have
even received FDA approval. Over the last two decades, the development of synthesis and
characterization  techniques  has  blossomed  for  engineered  new materials,  including  the
ability to manipulate molecules and supramolecular structures for beneficial functions. This
has led to the emergence of new DDS, such as inorganic delivery systems, for therapeutic
and/or diagnosis purposes.1–4 Compared to the conventional DDS, most inorganic-based
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DDS (e.g. mesoporous silica nanoparticles, MSNP) are still in their pre-clinical stages of
development, with a few exceptions. The inorganic DDS which have reached the furthest
stages  of  clinical  trials  are  gold  nanoparticles  (GNP)  used  in  drug  delivery  and
hyperthermia  based  treatments.  Figure.1.13  shows  the  leading  nanocarriers  for  drug
delivery and their general stages of development. The top row shows the representative
conventional  nanocarriers  such  as  liposomes,  micelles,  dendrimers,  and  polymers.  The
bottom row shows novel inorganic nanocarriers such as carbon nanotubes, quantum dots,
iron oxide, gold, and mesoporous silica nanoparticles
Figure 1.13 The scheme shows the leading nanocarriers for drug delivery and their
general stages of development . The top row shows the representative conventional DDS.
The bottom row shows novel inorganic nanocarriers[34]. 
1.4 Inorganic porous material for drug delivery
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Inorganic porous carriers have an organized porous structure, which provides them
with large inner surface areas (up to ∼1800 m2/g for MSNs like MCM-41, SBA-15)  high
surface to volume ratios,  large pore volumes (reaching values as  high as  1.7 cm3/g for
bimodal  mesoporous  silica-based  spheres  and  2.48  cm3/g  for  SBA-15)  tailorable  and
uniform pore sizes and well known possibilities of pore-wall functionalization allowing
them to host in their interior a wide variety drugs and molecules of interest. That large
inner surface area allows for the adsorption of large amounts of drugs or biomolecules
because adsorption is a surface-based phenomenon. Also, these structured porous materials
can be config-ured as micro- and nanoparticulated systems, fibers, monoliths, coatings, etc.
opening up their application in diverse medical fields.
The International Union of Pure and Applied Chemistry (IUPAC) classifies porous
materials  accord-ing to their pore sizes into three categories, namely microporous (with
pores below 2 nm), mesoporous (with pores between 2 and 50 nm), and macroporous (with
pores above 50 nm)[35]. Examples of porous materials are depicted in Figure1.14.
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Figure 1.14 Schematic diagram of porous materials classification by IUPAC with
examples of porous materials.
Porous  materials  are  widely  used  in  the  industry  principally  in  petrochemistry,
catalysis, selective separations, storage, as electrode materials, as insulation, and in sensors
and  actuators.  Porous structures  can  be organic,  inorganic,  or  hybrid  organic–inorganic
com-posites.  Both  attributes  together,  size  and  nature,  are  taken  into  account  when
designing  a  drug  carrier  for  delivery  applications.  The  main  advantages  of  using  a
structured porous material in drug delivery applications are:- (schematized in Figure 1.15)  
Advantages of inorganic porous materials as drug carriers 
 Large  surface  areas  together  with  their  large  pore  volumes  have  been  used     to
improve the solubility of poorly soluble drugs.
 Low density allows them to float in the gastrointestinal tract and prolongs the gastric
retention of oral drugs.
 Easy surface  functionalization allows  their  grafting  with  bioadhesive and  targeting
moieties,  and  their  interior  pore  volume  protects  biological  payloads  from
physiological degradation.
 Hydrophilic character and porous structure can in principle be tailored to control the
diffusion rate of an adsorbed or encapsulated drug, gene, or protein.
 They are resistant to microbial attack.
 They posses high chemical and mechanical stability under an array of physiological
conditions.
 They act as a volumetric reservoir (i.e., nanotubes, nanocapsules) also as a diffusion
controlling  porous  membrane  or  coating  in  drug-eluting  devices  (i.e.,  implants,
needles).
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 They can float in the gastrointestinal tract.
 They can adhere to different biological systems.
 Organized porosity has been used to achieve a sustained, controlled, or pulsed release
in drug delivery applications.
Figure 1.15 Schematic overview of some of the advantages described for porous
materials in drug delivery applications[36]. 
When compared to the properties of conventional and other inorganic nanocarriers,
MSNP have emerged as intermediary nanocarriers in the sense that they possess similar
biocompatibility as conventional nanocarriers as well as the durability and versatility of
ﬀinorganic nanocarriers. The intrinsically low toxicity of MSNP di erentiates it from many
other inorganic nanomaterials including other forms of silica-based nanomaterials such as
fumed silica and nano quartz that are associated with poor biocompatibility and toxicity
due to their highly reactive surface. (Detailed explanation given section 1.3.8)
1.5   Aerogels as a drug carrier
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Besides  their  high  surface  area,  pore  structure  and  low  density,  being
biocompatible,  makes  silica  aerogel  an  ideal  candidate  for  a  varieties  of  life  science
applications. Silica aerogel were firstly used in 1960s  as  an  additive  for  cosmetics  and
toothpaste  under  the  name  of  Monsant’s aerogels.  The production  has  lasted  for  few
years  until  silica  aerogel   was  replaced  by  the  cheap  fumed  silica. During  the
following  decades  aerogel  production  has  been  continuously  improved  resulting  in
spectacular properties and in the same time the cost factor was slowly minimized. In spite
the cost factor, silica aerogel is chemically identical with fumed silica; the later has been
proven to be used for pharmaceutics  and  food  industry  (Degussa,  2001),  furthermore,
silica  aerogel  characterized  with higher surface area (1000 m²/g) than that of fumed silica
(200 m²/g). These factors derive scientists to investigate silica aerogel as a carrier system
for different active compounds. However, it should be mentioned that a complete toxicity
investigations on silica aerogel are not available. In principle, active compounds can be
loaded on silica aerogel matrix following two main routes: Mixing the active compounds
drug  with  the  sol  before  the  gelation  takes  place,  followed  the  drying  step;  (2)  post
treatment  of  the  aerogel  in  a  way  that  allows  the  deposition  of  the  active  compound
particles on aerogel surface. 
The  stability  and  release  kinetics  of  the  active  substance  can  be  significantly
improved by loading of drug into the aerogel. Thus, the materials based on aerogels have a
great potential in the pharmaceutical, biomedical and many other fields. For certain active
substances in the aerogel matrix, it was shown the increase of the relative bioavailability as
compared  to  their  crystalline  form  more  than  twice.  Because  of  some  properties  of
aerogels, for example: different nature, the specific surface area and average pore size - the
best choice for of the active substance for a certain matrix.
An additional advantage compared with the nanoparticles is the fact that the drug
particles being adsorbed or crystallized in the solid aerogel matrix have a lower tendency to
agglomerate and are better protected from the environment. Other than surface area, the
hydrophilic silica aerogel  rapidly collapses in water.  The reason for this collapse is the
capillary  forces  which  are  exerted  by  the  surface  tension  when  liquid  water  enters  a
nanometre-scale pore of  the aerogel.  As a  result,  the solid  silica backbone is  fractured
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completely and the aerogel  loses its  solid integrity.  So the drug molecules adsorbed as
single molecules on the aerogel network are immediately surrounded by water molecules,
and thus dissolve faster [37]. Various drying techniques such as super critical drying, freeze
drying, ambient pressure drying techniques are used of which super critical drying uses
carbon dioxide liquid form as the solvent. Naturally it’s a expensive technique and for large
scale commercial production plans such routes of production must be avoided. Ambient
pressure drying suits well for large scale production[38]. aerogel microspherical particles are
produced using supercritical extraction of a gel-oil emulsion. Water in oil emulsion was
produced  by mixing the  sol  (dispersed  phase)  with  a  vegetable  oil  (continuous  phase)
followed by the gelation of the aqueous phase. The size and shape of the gel particles was
controlled  by  the  agitation  (agitator  shape  and  speed).  The  gel-oil  emulsion  was
subsequently extracted with supercritical CO2. Silica aerogel spherical microparticles with
a surface area of 1100 m²/g and mean particle diameters ranging from 200 µm to few
millimeters were produced. The resultant aerogel particles were loaded with a model drug
and  coated  with  different  polymeric  materials  in  a  spouted  fluidized  bed.  The
corresponding  polymers  were  sprayed  as  aqueous  solution  or  melts  and  the  coating
conditions (coating material, nozzle position, air flow rate, temperature etc) were optimized
accordingly. Drying of the coated aerogel was achieved by heating the bed with a hot air
stream. The physical, structural and release properties of the resulting formulations were
evaluated.  This  technology  allows providing specific  release  mechanism  of
pharmaceuticals[39]. 
1.6 Functionalized porous materials for controlled drug delivery
In recent years, mesoporous silica materials have been considered to be excellent
candidates as carriers for drug delivery. On the one hand, textural properties of mesoporous
silica increase the loading amount of drugs by hosting them within pore channels. On the
other hand, the silanol containing surface can be easily functionalized, allowing for a better
control  over  the  drug  diffusion  kinetics.19,20  In  addition,  multifunctional  mesoporous
silica composites with excellent magnetic and/or luminescent properties represent another
grand challenge for drug delivery targeting and tracking[40].  For normal aerogels ,  there
exist only silanol groups on the channel walls, and these silanol groups simply form weak
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intermolecular hydrogen bonds with drugs; hence, they are not strong enough to hold drugs
and  allow them to be released  in  a  sustained  manner.  The  need  to  synthesize  suitable
carriers to have specific host-guest interactions with drugs led us to introduce functional
groups on the surface of SBA-15. It has been reported that the organic functionalization of
SBA-15  can  be  achieved  via  two  different  routes,  i.e.,  one-pot  synthesis  (or  co-
condensation)[41,42] and postsynthesis (or silylation)[43-45]. 
 The method aims to enhance the loading of drugs in  aerogels by means of surface
functionalization of the carrier, and to investigate the influence of surface functional group
on the release rate of the loaded drug in aqueous media. Aminogroups are an example of
functional  groups.  Different  approaches  are  followed  to  control  the  surface
functionalization: pretreatment of the gel before the drying step, or a post treatment of the
aerogels. The obtained amino-functionalized aerogels can be characterized by NMR and
BET analysis,  and  UV-spectroscopy.  It  has  been  seen  that  the  functionalized  aerogels
maintain the same structural properties as the origin aerogels[46].
         1.7 Anti plateletic property of Aspirin
In  addition  to  its  effects  on  pain,  fever,  and  inflammation,  aspirin  also  has  an
important  inhibitory effect  on  platelets  in  the  blood.  This  antiplatelet  effect  is  used  to
prevent blood  clot formation  inside  arteries,  particularly  in  individuals  who
have atherosclerosis (narrowing  of  the  blood  vessels)  of  their  arteries,  or  are  otherwise
prone to develop blood clots in their arteries.
Antiplatelet  agents  are  medications  that  block  the  formation  of  blood  clots  by
preventing the clumping of platelets. There are three types of antiplatelet agents:
1. Aspirin,
2. Thienopyridines, and
3.Glycoprotein IIb/IIIa inhibitors.
These agents differ in the way they work, their potency (how strongly they prevent
clumping), how rapidly they work, and their cost. 
Aspirin
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Aspirin  prevents  blood  from  clotting  by  blocking  the  production  by  platelets
of thromboxane A-2, the chemical that causes platelets to clump. Aspirin accomplishes this
by inhibiting the  enzyme cyclo-oxygenase-1  (COX-1)  that  produces  thromboxane A-2.
While other NSAIDs also inhibit the COX-1 enzyme, aspirin is the preferred NSAID for
use as an antiplatelet agent because its inhibition of the COX-1 enzyme lasts much longer
than the other  NSAIDs (aspirin's  antiplatelet  effect  lasts days  while the other NSAID’s
antiplatelet effects last only hours).
        Thienopyridines
In  addition  to  thromboxane  A-2,  platelets  also  produce adenosinediphosphate
(ADP). When ADP attaches to receptors on the surface of platelets, the platelets clump. The
thienopyridines, for example, ticlopidine (Ticlid) and clopidogrel (Plavix), block the ADP
receptor. Blocking the ADP receptor prevents ADP from attaching to the receptor and the
platelets from clumping.
        Glycoprotein IIb/IIIa inhibitors
The glycoprotein  IIb/IIIa  inhibitors,  such  as abciximab (Reopro)  and  eptifibatide
(Integrilin), prevent clumping by inhibiting a different receptor on the surface of platelets,
the receptor for glycoprotein IIb/IIIa. The glycoprotein IIb/IIIa inhibitors that are approved
by the FDA must be given intravenously (in the veins); which is difficult to administer in
day to day life.
Since aspirin blocks only one of the several pathways by which platelet aggregation
can  occur,  aspirin  is  a  weak  antiplatelet  agent  because  platelet  aggregation  can  be
stimulated via another pathway.
Since glycoprotein IIb/IIIa inhibitors block the final common pathway for platelet
aggregation (platelet aggregation is blocked regardless of the nature of the initial stimuli),
glycoprotein  IIb/IIIa  inhibitors  are  the  most  potent  antiplatelet  agents.  The  maximal
antiplatelet  effect  of glycoprotein IIb/IIIa  inhibitors is  approximately nine times that  of
aspirin.
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The maximal antiplatelet effect of thienopyridines is in between that of aspirin and
the glycoprotein IIb/IIIa inhibitors.
         1.8 Mechanism of action
         Suppression of prostaglandins and thromboxanes
Aspirin's ability to suppress the production of prostaglandins and thromboxanes is
due to its irreversible inactivation of the cyclooxygenase enzyme required for prostaglandin
and thromboxane synthesis. Aspirin acts as an acetylating agent where an acetyl group is
covalently attached to a serine residue in the active site of the PTGS enzyme. This makes
aspirin  different  from  other  NSAIDs  (such  as diclofenac and ibuprofen),  which  are
reversible inhibitors.
Low-dose, long-term aspirin use irreversibly blocks the formation of thromboxane
A2 in platelets, producing an inhibitory effect on platelet aggregation. This antithrombotic
property  makes  aspirin  useful  for  reducing  the  incidence  of  heart  attacks.[115] 40 mg of
aspirin a day is  able to inhibit  a  large proportion of maximum thromboxane A2 release
provoked acutely, with the prostaglandin I2 synthesis being little affected; however, higher
doses of aspirin are required to attain further inhibition. [Tohgi, H; S Konno, K Tamura, B
Kimura and K Kawano (1992). 
Prostaglandins,  local hormones produced  in  the  body,  have  diverse  effects,
including  the  transmission  of  pain  information  to  the  brain,  modulation  of
the hypothalamic thermostat,  and  inflammation.  Thromboxanes  are  responsible  for  the
aggregation of platelets that form blood clots. Heart attacks are caused primarily by blood
clots,  and  low  doses  of  aspirin  are  seen  as  an  effective  medical  intervention  for
acute myocardial infarction. An unwanted side effect of the effective anticlotting action of
aspirin is that it may cause excessive bleeding.
        COX-1 and COX-2 inhibition
There  are  two  different  types  of  cyclooxygenase:  COX-1  and  COX-2.  Aspirin
irreversibly  inhibits  COX-1  and  modifies  the  enzymatic  activity  of  COX-2.  COX-2
normally  produces  prostanoids,  most  of  which  are  proinflammatory.  Aspirin-modified
PTGS2 produces lipoxins, most of which are anti-inflammatory. Endothelial cells lining the
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microvasculature in the body are proposed to express PTGS2, and, by selectively inhibiting
PTGS2, prostaglandin production (specifically, PGI2; prostacyclin) is downregulated with
respect to thromboxane levels, as PTGS1 in platelets is unaffected. Thus, the protective
anticoagulative effect of PGI2 is removed, increasing the risk of thrombus and associated
heart attacks and other circulatory problems. Since platelets have no DNA, they are unable
to synthesize new PTGS once aspirin has irreversibly inhibited the enzyme, an important
difference with reversible inhibitors.
Aspirin is readily broken down in the body to salicylic acid, which itself has anti-
inflammatory,  antipyretic,  and  analgesic  effects.  In  2012,  salicylic  acid  was  found  to
activate AMP-activated  protein  kinase,  and  this  has  been  suggested  as  a  possible
explanation for  some of  the effects of  both salicylic  acid and aspirin[123][124]. The acetyl
portion  of  the  aspirin  molecule  is  not  without  its  own  targets.  Acetylation  of  cellular
proteins  is  a  well-established  phenomenon in  the  regulation  of  protein  function  at  the
posttranslational  level.  Recent  studies  have reported aspirin  is  able  to  acetylate  several
other  targets  in  addition  to  COX isoenzymes.  These  acetylation  reactions  may explain
many hitherto unexplained effects of aspirin.
        
         Aspirin – Its onset of action
When aspirin is given in low doses (50 mg/day),  the complete inhibition of the
COX-1 enzyme and hence maximal antiplatelet effect may take several days. At a dose of
160-325 mg/day, the maximal antiplatelet effect of aspirin occurs within 30 minutes. Thus,
aspirin at low doses (75-150 mg/day) is used for the long term prevention of heart attacks
and strokes, whereas moderate doses (160-325 mg/day) of aspirin are given in situations
where an immediate anti-clotting effects are needed (such as in the treatment of acute heart
attacks and unstable angina).
1.9 Role of aspirin in preventing and treating heart attacks and strokes
Aspirin is widely used either alone or in combination with other antiplatelet agents
to  prevent  blood clots  from forming in  arteries.  Aspirin  is  used specifically in  several
situations including:
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1. Aspirin often is prescribed in moderate doses (160-325 mg/day) for patients who are
having heart attacks to limit the extent of damage to the heart's muscle (by preventing
blood clot formation in the blood vessels of the heart), prevent additional heart attacks,
and improve survival.
2.Aspirin often is  prescribed to patients undergoing surgery to open or bypass blocked
arteries,  including  percutaneous  transluminal coronary  angioplasty (PTCA)  with  or
without placement of coronary stents (CABG). Aspirin also is prescribed on a long-
term basis to prevent clotting in the stents and/or the bypassed blood vessels.
3.Aspirin often is prescribed in low doses (50-160 mg/day) on a long-term basis to patients
with  prior  heart  attacks  or  strokes  and  to  patients  with  TIAs  (transient  ischemic
attacks or  mini-strokes) and exertional  angina to prevent heart  attacks and ischemic
strokes.
4.Aspirin may be used in low dose (50-160mg/day) for prevention of heart attack or stroke
in  patients  with  risk  factors  of  these  conditions  including  longstanding  diabetes,
vascular disease (previous heart  attack or stroke,  or poor circulation to the legs),  or
angina.  Aspirin often is prescribed in moderate doses (160-325 mg/day) for patients
who are having heart attacks to limit the extent of damage to the heart's muscle (by
preventing blood clot formation in the blood vessels of the heart), prevent additional
heart attacks, and improve survival.
5.Aspirin often is  prescribed to patients undergoing surgery to open or bypass blocked
arteries,  including  percutaneous  transluminal coronary  angioplasty (PTCA)  with  or
without  placement  of  coronary stents  and  coronary artery bypass  surgery (CABG).
Aspirin also is prescribed on a long-term basis to prevent clotting in the stents and/or
the bypassed blood vessels.
6.Aspirin often is prescribed in low doses (50-160 mg/day) on a long-term basis to patients
with  prior  heart  attacks  or  strokes  and  to  patients  with  TIAs  (transient  ischemic
attacks or  mini-strokes) and exertional  angina to prevent heart  attacks and ischemic
strokes.
7.Aspirin may be used in low dose (50-160mg/day) for prevention of heart attack or stroke
in  patients  with  risk  factors  of  these  conditions  including  longstanding  diabetes,
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vascular disease (previous heart  attack or stroke,  or poor circulation to the legs),  or
angina.
8. Aspirin is prescribed in moderate doses (160-325 mg/day) to patients who are having
unstable angina to prevent heart attacks and improve survival.
9. Aspirin is prescribed in moderate doses (160-325 mg/day) to selected patients who are
having ischemic strokes to limit  damage to the brain,  prevent  a  second stroke,  and
improve survival.
 Treatment of heart attacks
In a large multi-center study (Second International Study of Infarct Survival of the
ISIS-2 trial) of patients having acute heart attacks, early treatment (within 24 hours of the
onset of symptoms) with aspirin (160 mg/d) was found to reduce deaths from the heart
attacks by 23%. The improved survival is believed to be due to aspirin's ability to quickly
prevent further blood clots and the expansion of existing clots and thus limit the amount of
damage to the heart's muscle.
Aspirin is easy to use, safe at the low doses used for its antiplatelet action, and fast
acting. Aspirin at moderate doses (160-325 mg/day) produces an antiplatelet effect rapidly
(within 30 minutes). The current recommendation is to give aspirin immediately to almost
all  patients  as  soon as  a  heart  attack is  recognized at  a  dose of  160-325 mg/d  and to
continue it for one month. The only reason for not using aspirin is a history of intolerance
or allergy to aspirin or evidence obvious active bleeding (such as actively bleeding stomach
ulcers).
        Prevention of further heart attacks
There are two types of heart attack prevention, primary and secondary. Preventing
the first heart attack is called primary prevention. Preventing further heart attacks among
patients who already have had a heart attack is called secondary prevention.
Within six years after the first heart attack, 16% of men and 35% of women will
have a second heart  attack.  Long-term, daily aspirin (75-325 mg/d)  has been shown to
reduce the risk of second heart attacks and improve survival among both men and women.
Additionally,  long-term  secondary  prevention  with  aspirin  also  has  resulted  in  fewer
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ischemic (lack of blood flow due to blockage in blood vessels from clot formation) strokes.
Therefore, survivors of heart attacks usually take daily low dose (75 mg-160 mg/d) aspirin
indefinitely to prevent further heart attacks as well as strokes.
Aspirin  taken  long-term  is  an  important  part  but  NOT  the  only  measure  for
preventing heart attacks.
        Prevention of strokes
Patients  with  prior  strokes  and  TIAs  (mini-strokes)  usually  have  significant
atherosclerosis of the carotid and /or the smaller arteries within the brain and are at risk of
further strokes. (These patients often have coronary atherosclerosis as well and are at risk
for heart attacks). Long-term low-to-moderate doses of aspirin (50-325 mg/d) have been
found to reduce the risk of strokes as well as heart attacks in these patients.
Aspirin  is  not  the  only  medication  to  prevent  strokes  among  patients  with
atherosclerosis.  Another  anti-platelet  agent,  clopidogrel  (Plavix),  also  has  been  used,
especially  in  patients  who  are  intolerant  or  allergic  to  aspirin.  Aspirin  is  sometimes
combined  with  a  second  anti-platelet  agent,  dipyridamole  (Persantine,  Aggrenox),  to
prevent strokes.
Antiplatelet agents are not the only measures that prevent strokes.  For example,
aspirin alone may not be sufficient to prevent embolic strokes in patients at risk for these
strokes, such as in patients with atrial fibrillation. In these patients, warfarin (Coumadin),
an  oral  anti-coagulant  that  is  a  stronger  anti-clotting  medication  than  aspirin,  may be
necessary.
In patients with ischemic strokes or TIAs who have advanced atherosclerosis and
narrowing of the carotid arteries, carotid endarterectomy (a surgical procedure to widen the
narrowed carotid artery,  the main blood vessel  feeding the brain) or the introduction of
stents within the carotid artery may be necessary to prevent strokes. As described below,
the recommendations for the secondary prevention (in people who already have had a heart
attack or stroke) of future attacks are more compelling. An ideal dose of aspirin is one that
maximizes its benefits but minimizes side effects. However, the ideal dose of aspirin for
primary  or  secondary  prevention  of  ischemic  strokes  and  heart  attacks  has  not  been
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established firmly. At lower doses, such as 50-75 mg/d, the antiplatelet effect of aspirin can
be achieved in several days instead of minutes.  Since the risk of serious bleeding from
aspirin is lower at lower doses, 50-75 mg/d is an appropriate dose for long-term primary
and secondary prevention. Even though aspirin at doses as low as 40 mg/d has been shown
to have anti-platelet effects, there is insufficient and inconclusive data to show that such
low doses are effective in preventing heart attacks and ischemic strokes.
The USPSTF also looked into the optimal dose of aspirin for primary preventive
purposes in 2009. They concluded that the low doses of 50-100mg daily were as effective
as  higher  doses  in  preventing  vascular  disease  and  less  associated  with  bleeding
complications.
Aspirin  taken  long-term  is  an  important  part  but  NOT  the  only  measure  for
preventing heart attacks.
Prevention of strokes
Patients  with  prior  strokes  and  TIAs  (mini-strokes)  usually  have  significant
atherosclerosis of the carotid and /or the smaller arteries within the brain and are at risk of
further strokes. (These patients often have coronary atherosclerosis as well and are at risk
for heart attacks.) Long-term low-to-moderate doses of aspirin (50-325 mg/d) have been
found to reduce the risk of strokes as well as heart attacks in these patients.
Aspirin  is  not  the  only  medication  to  prevent  strokes  among  patients  with
atherosclerosis.  Another  anti-platelet  agent,  clopidogrel  (Plavix),  also  has  been  used,
especially  in  patients  who  are  intolerant  or  allergic  to  aspirin.  Aspirin  is  sometimes
combined  with  a  second  anti-platelet  agent,  dipyridamole  (Persantine,  Aggrenox),  to
prevent strokes.
Aspirin  prevents  blood  clots  from  forming  inside  arteries  affected  by
atherosclerosis, but aspirin does not prevent atherosclerosis. Other measures (losing excess
weight,  controlling high  blood  pressure and  diabetes,  lowering  LDL  cholesterol,
increasing HDL cholesterol,  and  stopping  cigarette  smoking)  are  necessary  to  prevent
atherosclerosis.
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Most physicians these days recommend low doses of aspirin long-term for patients
with advanced atherosclerosis for secondary prevention purposes.  Such patients include
those with:
• prior heart attacks
• prior strokes
• exertional and unstable angina
• TIAs (transient ischemic attack, mini-stroke)
• peripheral vascular disease (poor artery blood flow to the legs)
• vascular procedures such as PTCA and CABG
Doctors also consider low dose aspirin in patients at risk for atherosclerosis because
they:
• Have high blood LDL cholesterol
• Are males over 45 or are postmenopausal or over 55 females
• Have high blood pressure (hypertension) after high blood pressure is controlled
with medications
• Use tobacco
• Have diabetes mellitus
• Have a family history of coronary heart disease
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2. REVIEW OF LITERATURE
Manuel Arruebo et al.  [47] demonstrated the numerous possibilities of structured porous
inorganic materials in drug delivery applications in their review. The focus of the current
research in designing targeted drug delivery systems using inorganic porous materials was
elucidated. It describes the use of porous inorganic materials such as mesoporous silicas,
hydroxyapatites,  tricalcium  phosphates,  aluminosilicates,  mesoporous  carbons,  MOFs,
porous silicon, PMO, calcium silicates, ceramic and carbon based nanotubes, and layered
silicates  numerous possibilities in the biomedical field. 
Krajewski et al. [48] worked on hydroxyapatite and bio inert alumina as a porous source of
drug delivery devices. Possibility to control pore size was taken into consideration. The
release  of  the  drug  was  carried  out  pharmacologically.  This  study allowed  a  plausible
interpretation of the phenomena involved in releasing a substance with pharmacological
activity and simple molecular structure from ceramic samples with different porosimetric
intervals, preventively impregnated with that substance. They conclude it as a preliminary
work targeted in preparing ceramic drug delivery systems. The dimensions of pore size
distribution influence the degree of efficiency of release mechanism of drugs. Advantage of
bimodal pores over monomodal porous system was elucidated for better drug release also
pointing out the better combinations of size and amount of the two classes of pores. 
Keji Yamamoto et al. [49] studied the adsorption and entrapment of salicylamide molecules
into folded sheets of mesoporous (FSM-16). The study concluded that the heat treatment of
the physical mixture of salicylamide with FSM-16 gives a solid dispersion in which drug
molecules change to amorphous and adsorb into carrier; in turn showed good release. The
adsorptive  ability  of  FSM-16  micropores  might  promote  the  rapid  adsorption  of
salicylamide. From the thermal analysis, it was found that the salicylamide adsorbed could
exist in an amorphous state stably. It was revealed that the solid dispersion of salicylamide
and FSM-16 was useful in achieving fast dissolution of salicylamide. 
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M. Vallet Regi et al. [50] studied MCM-41 as a potential source of drug delivery carrier. The
disordered pores found on the surface of siloxane bridges and free silanol groups were
studied. Also cited the two main factors that determine the drug loading i) Pore wall surface
and ii) functional group present in the surface. Hence they performed functionalization as
well as changing the drugs as separate trails in the study. XRD of both MCM-41 and amine
modified MCM-41 shows how the functionalization of the pore wall does not affect to the
structural order. This study evidences that the host-guest chemistry in MCM-41 materials
can  be  conveniently  manipulated  as  to  fine  the  adsorption  and  delivery  behavior  of
molecules of pharmacological interest. 
Wei Zeng et al. [51] conducted experiments on MCM-41 materials by organic aminopropyl
modification.  Solvothermal  process was adopted.  Aspirin  was utilized in the controlled
drug delivery system. The release study was conducted and use of various aminopropyl
groups on the pore wall  was studied.  Characterization carried out by XRD, TG, FTIR,
TEM, UV. The results show that the release properties of this delivery system are affected
by  the  amount  of  aminopropyl  groups  on  the  pore  wall  and  the  ordered  structure  of
mesoporous materials, which indicates that appropriate organic functional groups and post-
treated time are favorable for the drug delivery. 
Kim et  al. [52] reported composites of enzyme molecules and magnetite nanoparticles in
hierarchically  ordered,  mesocellular,  mesoporous  silica  via  a  ship-in-a-bottle  approach.
These  two kinds  of  nanocomposites  could  respond  well  to  a  magnetic  field,  they had
irregular article shapes and sizes. A Magnetically Separable, Highly Stable enzyme System
Based on nanocomposites of enzymes and magnetic nanoparticles Shipped in hierarchically
ordered, mesocellular, mesoporous silica. 
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S. Kawi et al.[53] Functionalized mesoporous SBA-15 with amino silane and resultant white
solid  was  filtered  off.  The  resultant  functionalized  materials  were  investigated  for
controlled  drug  delivery.  The  characterization  studies  were  carried  out  with  FTIR,  N2
adsorption/desorption analysis,  zeta  potential,  XRD, TEM etc.  The drugs  selected were
Ibuprofen and Bovine serum albumin. Since, in-vitro dissolution testing is important for
drug development  and quality control,  it  has  been used in  this study to  investigate the
difference in the release rate of model drugs from SBA-15 samples into biological medium.
The surface properties of functionalized SBA-15 materials have been shown to be tunably
modified using two different  routes,  namely,  one-pot  synthesis  and post  synthesis  Post
synthesis  technique  was  found  to  be  most  favorable  for  drug  release  that  the  one  pot
synthesis.
Qunli Tang et al. [54] conducted separate experiments on MCM-41 with and without surface
modification. He found that those without modification released ibuprofen within an hour
and when surface functionalization done with hexamethyldisilazane (HMDS). The release
was  70%  after  48  hours  elucidating  the  controlled  release  nature;  the  amount  of
functionalization also determined the rate of release.  The XRD pattern of the MCM-41
indicates a typical pattern for a hexagonally ordered MCM-41 with strong reflection peaks
in (100),  (110),  and (200).  The  diffraction intensities  of  these  corresponding peaks are
markedly decreased for the MCM-41(ibuprofen loaded). This is likely due to the larger
contrast in density between the matrixes and open pores MCM-41 relative to that between
the matrix and ibuprofen filled in pores MCM-41(Ibuprofen loaded). 
Hubert Koller [55] worked on producing self assemble silica and hybrid organosilica sol-gel
materials. To it a pharmaceutically important Presantin was loaded. Larger pores and faster
release were observed at weakly acidic range (pH 5.6) whereas, more dense materials and
slow release at pH 2-3. The organically functionalized host gels can control drug release.
To  gain  a  deeper  insight  into  the  kinetics,  1H and  29Si  NMR spectroscopy have  been
employed  in  situ  on  the  reaction  solutions  of  tetraethyl  orthosilicate  (TEOS)  and
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acetoxypropyltrimethoxysilane (ATS). The drug is closely surrounded by the gel matrix,
leading  to  the  inhibition  of  the  release  profile.  Therefore,  the  fact  that  no  nitrogen  is
adsorbed for these gels must be explained by N2 diffusion blockage. The use of ATS side
groups  in  an  inorganic-organic  hybrid  gel  leads  to  promising  release  properties.  The
porosity of the carrier gel shows a bimodal pore-size distribution as measured by positron
annihilation lifetime experiments (PALS). 
Rajendra Kumar et al. [56] elucidated the use of a novel hybrid nano structured sponge to
conduct studies in the concept of oral delivery of peptides employing a model drug for
loading insulin.  The modified sponge was acid-base neutralized for  hydroxyapatite  and
incorporating chitosan as the organic counterpart. The films showed good insulin loading
and alginate could be coated on them so as to release the drug only on gastric and intestinal
pH. The drug release can be rationalized as drug adsorbed on to the surface and into the
nanoporous architecture. The proof of concept of using the organic- inorganic sponge of
nano structured, non-toxic materials was apt to deliver a peptide drug, insulin was studied.
In vitro release proved good in both the simulated body fluid and also simulated intestinal
fluid for the test hypothesis. 
Jesus Santa Maria et  al. [57] synthesized metallic iron nano particle  with  micron sized
mesoporous  molecular  sieves  (MCM-41  and  MCM-48).  Several  cycles  of  wet
impregnation under vacuum, followed by drying, oxidation and reduction steps. These iron
loaded hollow silica micro capsules showed magnetic moment of 2.4 emu/g after 3 cycles
and coercivity. The wet impregnation technique was used to load iron within the structure
of  the  prepared  powder  (particles)  and  microcapsules.  In  a  typical  procedure,  the  air
contained within the pores and cavities of these materials was first removed under vacuum,
and  then,  1.6  M  Fe(NO3)3.9H2O  solution  was  admitted  into  the  vessel  to  carry  out
impregnation at atmospheric pressure. It was inferred from the study that because of the
high volume of their internal cavities, the microspheres are capable of delivering a higher
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drug load. Both groups of materials (MCM-41 and MCM-48) can therefore be considered
as very promising materials for application in drug delivery. 
Maria Vallet-Reji et al. [58] addressed the growing interest towards using MCM-41, SBA-
15, and MCM-48 as potential drug delivery carriers. Introduction of other metal-organic
frameworks have also been postulated for the same. The drug incorporation is commonly
carried out by soaking of the matrix in a highly concentrated drug solution and subsequent
drying. Therefore, the process is mainly based on the adsorptive properties of mesoporous
materials.  They also proposed the application could be extended towards bone implants
citing  these  materials  as  a  potential  bioceramic  which  can  be  concluded  using
biocompatibility  studies  of  these  functionalized  materials  which  in  turn  act  as  stimuli-
response systems. For certain applications, the delivery of adsorbed molecules needs to be
modulated  by  environmental  stimuli  such  as  pH  and  temperature  changes  or  light.
Furthermore, many site-selective delivery systems, such as those for highly toxic antitumor
drugs, require zero release before the targeted cells or tissues are reached. Current research
is focused on the design of ordered mesoporous materials with certain functional groups
that  respond  to  environmental  changes  and  thus  modify  the  adsorption  and  release
characteristics. 
Shizhang Qiao et al. [59] reported a novel one step synthesis pathway that controls both
functionality and morphology of functionalized periodic helical mesostructured silica by
co-condensation  of  TEOS  and  organoalkoxysilane  (hydrophobic)  ones.  The  use  of
surfactants  as  templates  was  demonstrated.  Thiol  functionalized  helical  mesostructured
silica  was  synthesized  by  the  co-condensation  of  TEOS  and  MPTS  using  16CTAB or
18CTAB as a surfactant, without the use of any additives. The amount of MPTS was varied
from 0.0 to 0.1g to investigate its effect on the formation of the helical mesostructures.
Helical mesostructures were formed with hydrophobic groups with surfactants and thereby
formation of helical rod likes cylindrical micelle forming structures. The work is the first of
its  kind  of  a  one-step  synthetic  pathway  that  can  control  both  functionalities  and
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morphology of functionalized periodic helical mesostructured silica by the co-condensation
of TEOS and hydrophobic organoalkoxysilane using achiral surfactants as templates. The
morphology  and  pitch  of  the  helical  structure  was  controlled  by  the  amount  of
organoalkoxysilane. 
Lee et al.  [60] reported synthesis of mesoporous silica nanoparticles (MSN) with different
densities  of  positive charge.  The positive charge brought about by the functionalization
with trimethylammonium (TA). Colon related diseases such as irritable bowel syndrome,
Crohn’s  disease,  and  ulcerative  colitis  could  be  more  effectively  treated  when  the
therapeutic drugs are delivered to the colon tissue. Studies were carried out using Orange II
a fluorescent tracer molecule and an anti-inflammatory prodrug sulfasalazine were used.
Effects of environmental pH (from 1 to 10) on the adsorbed amounts of Orange II and
sulfasalazine  molecules  onto  MSN-TA  samples  were  investigated.  A  pH-responsive
controllable drug release system has been designed by the authors by incorporating positive
charges in the framework of MSN so that anionic molecules can be efficiently adsorbed
inside of the nano channels with minimal release under acidic pH value.  The sustained
release at pH 7.4 due to partial static negative charge development was explained targeting
the intestine. 
Ashish Datt [61] carried out his PhD on mesoporous silica and zeolites for drug delivery.
Zeolites and mesoporous silica were used as drug delivery systems for the loading and
release of  small  drug molecules,  aspirin  and 5-fluorouracil.   Different  parameters were
varied  such  as  aluminum  content  in  the  zeolite,  effect  of  distribution  of  functional
groups and the method of surface modification in case of mesoporous silica. The effect of
the  aforementioned  variables  was  studied  on  drug  loading  and  release  from  these
microporous  and  mesoporous  systems.  The  drug  loaded  materials  were  extensively
characterized  using  various  physical  techniques  such  as  powder  X-ray  diffraction,
nitrogen  isotherms,  infrared  spectroscopy,  solid  state  NMR  and  thermo gravimetric
analysis. Quantum calculations  and  molecular  dynamics  simulations  were  performed  in
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order to validate the experimental data and also to obtain a molecular level insight of the
drugs   inside   the   pores   of   the   host   materials.   Drug   templated   synthesis   of
mesoporous silica  was  also  carried  out  in  the  presence  of  aspirin  as  the  template.
The  aspirin templated  material  was  characterized  by  aforementioned  techniques  and
showed  a sustained drug release profile. 
Tewodros Asefa et al. [62] showed that drug incubation temperature and methods which were
employed removing surfactant template from mesoporous materials and the solvents used
for surface functionalization also has a affect on the drug absorption and release properties.
Rhodamine 6G and cisplatin anti cancer drugs were selected for studies on mesoporous
silica  (MCM-41  &  SBA-15).The  comparative  studies  of  organic-functionalized
mesoporous  dependent  on  not  ony  the  temperature  but  also  the  concentration.  Study
revealed the change in room temperature to 50oC and 75oC has a say on drug loading and
drug release correspondingly.  The experiments on cisplatin also confirmed the effect of
temperature. The adsorption and release properties toward R6G and cisplatin of ethane-
functionalized periodic mesoporous organosilica (ethane PMO) were also investigated. The
ethane PMO was found to adsorb a higher amount of R6G than MCM-41. 
Shizhang Qiao et al. [63] also carried out the work of magnetic nanoparticles coating on
silica or polymers has been extensively applications explored in biomedical fields such as
targeted drug delivery and magnetic resonance imaging. A pH-responsive controllable drug
release system has been designed by incorporating positive charges in the framework of
MSN so that anionic molecules can be efficiently adsorbed inside of the nanochannels with
minimal  release  under  acidic  pH  value.  The  particle  size,  shell  wall  thickness,  and
saturation  magnetization  value  of  periodic  mesoporous  organosilica  magnetic  hollow
spheres  are  tunable  by  varying  the  amounts  of  fluorocarbon  surfactant  and  magnetic
nanoparticles.  The  pore  surface  properties  can  be  adjusted  by  the  co-condensation  of
BTME with functional  silane precursor.  The high saturation magnetization ensures  that
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these functional mesoporous hollow spheres become a very efficient protocol to targeted
drug delivery assisted by magnetic fields. 
Shefan  Kaskel  et  al.[64]  studied  the  synthesis  of  Rattle-type  Fe3O4@SiO2 hollow
mesoporous spheres with large cavities using the colloidal carbon spheres as the templates.
The spheres are well monodisperse and nearly uniform in dimension with particle size of
ca. 900 nm. The thickness of the mesoporous silica shell is about 100 nm, and only one
Fe3O4 particle of ca. 100 nm in diameter is encapsulated in each hollow mesoporous silica
sphere. The magnetic measurement indicated that the Fe3O4@SiO2 hollow mesoporous
spheres exhibited ferromagnetic behavior with the magnetization saturation of 1.6 emu/g.
Using aspirin as a model drug, the Fe3O4@SiO2 hollow mesoporous spheres showed high
drug loading capacity and sustained release property. Therefore, it was demonstrated that
magnetic hollow mesoporous spheres provides a very promising candidate for application
in a targeted drug delivery system. 
Si-Xue Cheng et al. [65] studied the sustained release profile of Doxorubicin hydrochloride
on  the  synthesized  CaCO3/CMC  hybrid  microspheres  and  nanospheres.  The
characterization  carried  out  by Scanning  electron  microscopy,  FTIR,  X-ray diffraction,
TGA etc.  High  encapsulation  and  sustained  release  profile  was  seen  from  micro  and
nanospheres. By taking into account the SEM studies and other experiments envisaged the
CaCO3 microparticles were prepared in the presence of highly nanoporous polysaccharides
which provide a  strong capability to  load drugs.  The drug (Doxirubicin  hydrochloride)
loaded microspheres were examined under the confocal microscope followed by DSC for
the  comparison  of  both  blank  and  drug  loaded  micro  /  nanospheres.  Drug  loaded
microspheres were immersed in physiological buffer solution. At predetermined intervals
samples were taken and replaced with equal amount of the buffer solution and analyzed by
UV-Visible spectroscopy.  
Michelina  Catouro  et  al. [66] worked  on  bringing  out  and  characterize  novel  sol-gel
organic-inorganic  hybrid  materials  for  controlled  drug  delivery  applications  based  on
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poly(ε-caproactone)  PCL 6,12,24 &50 wt%)  and zirconium-ytria (ZrO2.5%Y2O3). This
was done by using multicomponent solutions. Characterizations were done by FTIR, NMR.
Release  kinetics  carried  out  in  simulated  body  fluid  and  analyzed  in  UV-Visible
spectroscopy  for  anti  inflammatory  drugs. The  presence  of  hydrogen  bonds  between
organic-inorganic components of the hybrid materials was suggested by Fourier transform
infrared (FTIR) analysis, and strongly supported by solid-state NMR. A single-step, sol-gel
process was then used to precipitate microspheres containing ketoprofen or indomethacin
for controlled drug delivery applications. Release kinetics in a simulated body fluid (SBF)
was  subsequently  investigated.  The  amount  of  drug  released  was  detected  by UV-VIS
spectroscopy. Pure anti-inflammatory agents exhibited linear release with time, in contrast
drugs entrapped in the organic-inorganic hybrids were released with a logarithmic time
dependence, starting with an initial burst effect followed by a gradual decrease. Pure drugs
showed linear release whereas inorganic-organic showed controlled one. 
Timo Lebold [67] described how mesoporous materials act as an ideal drug delivery carrier
in a drug delivery system. The tuning of pore size and its effect on drug binding property
was also studied. The characterization was done using XRD and C13-NMR. The release or
diffusion dynamics studied and correlated diffusion coefficients to pore distance. This is the
first  time that  fluorescence  spectra  of  Doxorubicin  in  such  diluted  samples  have  been
acquired. At high concentrations (from 10-2 mol/L down to 10-6 mol/L) the spectrum is
blue-shifted with a major band at 600 nm. At a concentration of 10-7 mol/L the spectrum
gets shifted to the red with a peak at 645 nm. This change in spectrum is attributed to
aggregation.  The  dimerization  process  could  lead  to  an  increase  of  internal  hydrogen-
bonding with  the  oxygen  atoms in  the  silica  walls,  reducing  the  attractive  interactions
between drug and host. The structurally related cytostatic Actinomycin D indeed aggregates
to  inverted  dimers Pluronic  P123  templated  mesoporous  films  were  loaded  with
Doxorubicin (Doxorubicin concentration in the synthesis solution 10-4 mol/L) in order to
determine the drug release kinetics. The P123 templated structures were chosen for this
experiment  because  Pluronic  is  well-known  as  biocompatible  micellar  nanocarrier  for
pharmaceuticals, such as Doxorubicin. 
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Robin H Bogner et al.  [68] explained the use of mesoporous materials as amorphous drug
delivery system. Attempts were made to study the interaction of crystalline compounds
with mesoporous media.  For  this synthesis  of  various  types  of  mesoporous silica were
prepared. Because of the large surface area, complex surface chemistry, and heterogeneous
surface structures, their interaction with a drug compound in a formulation is often different
and more complex than a nonporous excipient. Method of preparing amorphous drug silica
formulations  was  studied.  Organic  solvent  was  used  to  introduce  drug  compound  to
mesoporous silica. Drug was first dissolved in an organic solvent to form a concentrated
solution.  Using  solvent  impregnation  method,  the  properties  of  organic  solvents  likely
contribute  to  the  efficiency of  drug loading.  The  effect  of  a  solvent  is  first  discussed,
followed  by  the  in  vitro  and  in  vivo  performances  of  amorphous  formulations.  The
transformation mechanism of drug in the presence of mesoporous excipients can be rather
advantageous in formulating and delivering poorly soluble compounds to achieve higher
bioavailability. 
Michael Froba et al. [69] explained the rise of a new class of materials; organic-inorganic
hybrid materials.  They utilized the two sides;  inorganic part  builds the robust  substrate
while  organic part  shows them for  the number of  ways  the material  can be used.  The
potential application in targeted drug delivery, magnetic resonance imaging etc were also
explained. Highlighted part includes biocompatibility and biodegradability apart from high
surface area, larger pore size and volumes. Some of the presented organosilica materials
possess performances that are already superior in comparison to the conventional ones, for
instance in the field of chromatography. The author concludes that the material possesses
good property compared to conventional ones but cost effectiveness can be brought in to
account only with large scale production. 
Michela Signoretto et al. [70] synthesized pure and modified silica materials by using sol gel
process.  This  was  then  implemented  as  a  carrier  for  controlled  release  of  ibuprofen.
Ibuprofen was selected as the model drug. One step synthesis was proposed and optimized
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for  preparation  of  silica  dry  composites  by  using  tetraethylorthosilane  (TEOS)  &  3-
aminopropyl triethoxy silane (APTMS) at different molar ratios. The desorption of drug
becomes process controlled by the presence of amino propyl groups were explained using
various characterizations. All silica carriers studied in this work have been prepared by a
one-step synthesis following the sol–gel method. The IR investigation showed the presence
of the surface OH groups with its relative peaks. And later on when drug is adsorbed there
is a broader peak due to the mutual interaction of hydrogen bond. This low-temperature
process offers several advantages: in particular, it assures high homogeneity of the final
products.  Silica-ibuprofen  tablets  were  functionalized  with  different  amount  of
aminopropyl  groups  and  evaluated  the  effect  of  the  organic  groups  amount  on  the
properties  of  the  obtained  carriers  (physicochemical  properties,  stability)  and  on  drug
delivery performance.
  
Jun Lin et al. [71] explained how work on drug delivery was carried out on mesoporous
silica  which  is  biocompatible.  Implementation  of  magnetism  and  luminescence  was
brought  in  for  various  biotechnological  and  bio  medical  applications.  The  ordered
mesopores  at  the  shells,  on  the  one  hand,  can  provide  accessible  channels  for  drug
molecules diffusion and mass transfer without blocking; on the other hand, could control
the  permeability  of  the  shells  for  matter  exchange  between  voids  and  the  outer
environment. Magnetic nanoparticles, an important category of inorganic material finds its
application for targeted drug delivery. The work guides us through how mesoporous silica
is used in drug delivery and how functionalization helps followed by the explanation of
stimuli-response  controlled  release  systems.  Bio-stimuli  responsive  to  deliver  desirable
molecules involving antibodies, nucleotides need to act as to uncap the mesoporous silica
materials at that point.   
Siling Wang et al. [72] studied the applicability of chitosan to regulate drug release rate for
porous silica for which; coated spherical non silica matrix with chitosan. Carvidiol used as
model drug and was loaded using solvent evaporation technique. Charecterization using
TEM, XRD, DSC & TGA proved the drug loading. It was inferred that chitosan in acidic
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environment showed swelling nature and in the alkaline in is shrinking showing controlled
release. The dissolution profiles of the raw drug and drug-loaded composite were studied
by using a USP II paddle method with a dissolution apparatus. All dissolution studies were
carried out under sink conditions in triplicate. Enzyme free simulated intestinal fluid was
used  as  the  medium  of  release.  The  chitosan  coating  process  was  achieved  by  a
postsynthesis approach. The group also studied the swelling property of chitosan grafted
silica. 
Yingjug Wang et al. [73] studied the use of hierarchically porous hydroxyapetite microsphere
for their role in drug delivery. The work also highlighted the use of citrate which brings
with it a dual role of converting the dumb bell shaped hydroxyapatite to individual spheres
and  importantly  a  stimuli  release  mechanism.  The  reaction  was  done  using  one  pot
synthesis  with  vancomycin.  In-vitro  of  the  vancomycin  was  performed when  0.02g  of
sample in 20 ml of a media of phosphate buffer, stirring for 12h at room temperature. The
group  successfully  prepared  MHAp  with  a  hierarchical  porous  structure  with  the
thermodynamic treatment to bring with it a controlled release without burst release to make
it a promising drug delivery vector. Summarized in their review about the basic idea behind
the chemical design classical inorganic porous material: aerogel. The review passes through
main heading of sol-gel chemistry, the structure of the gels, and the resulting properties of
the light weight aerogel material. In the review, postulate of exchanging the pore liquid
which  is  traditional  method  showed  that  it  maintains  the  filigrane  solid  network.  The
various  drying  techniques  such  as  supercritical  drying  and  ambient  pressure  were
elucidated. The versatility with which these aerogels can be used as aerogel films, carbon
aerogels and hybrid inorganic-organic aerogels were also reported. The authors conclude
that preparation of aerogels is “nanotechnology” which possesses unique optical, thermal,
acoustic and mechanical properties. Ambient pressure drying brings new light in to this
field as aerogels can be prepared in normal laboratory scale.  
Shah et al. [74] reviewed the Pharmaceutical applications of aerogels. The author identified
aerogels one of the emerging and most promising means of drug delivery system. In this
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review,  it  was  reported  that  along  with  the  innovative  properties  such  as  low thermal
conductivity, refractive index, thermal stability, and large surface area biocompatibility of
aerogels, make them a potential candidate as a drug carrier. 
Smirnova  [75] has  given a  detailed  overview  of ‘Pharmaceutical  Applications  of
Aerogels’ in her book chapter. Biocompatible aerogels and composite aerogel materials in
life science, especially in biomedical and pharmaceutical applications were reviewed. Due
to their  large  surface area,  open pore structure,  and biocompatibility,  aerogels  are very
promising candidates for drug delivery systems. The use of both inorganic and organic
aerogels  as carriers  for  pharmaceutically active compounds is  discussed in  the chapter.
Both the stability and the release kinetics of the drug can be significantly improved by
loading them into aerogels. First attempts to prepare semisolid and solid pharmaceutical
formulations have been mentioned. Furthermore, aerogels applications as host matrix for
bioactive  compounds  (enzymes  and  proteins)  were  elucidated.  Taking  into  account  all
research  activities  in  the  area  of  aerogels,  a  number  of  promising  pharmaceutical
applications can be expected in future. Extensively carried out her work on aerogels as
tailor made carriers  for  drug release.  The potential  of  inorganic polymeric materials  of
silica  was  studied.  Poorly  soluble  drugs  can  be  adsorbed  on  silica  aerogels  and  gets
distributed  in  molecular  level.  The  possibility  of  producing  both  hydrophilic  and
hydrophobic gels  was studied.  The loading of aerogels  with  drugs  was reported as the
maximum possible loading that could be achieved by the application of supercritical CO2
environment. Several factors come in to play major role. The hydrophilic silica aerogels
rapidly collapses in water so drug might be abruptly released. Hydrophobic aerogels have
higher  density  and  have  comparatively smaller  pore  size  permitting  a  more  controlled
release of the drug entrapped within.
Rakesh Patel et al. [76] envisaged the work on silica aerogels seeing their wide potential &
applications. The article explains the multi dimensional use of aerogels in various fields
such  as  molecular  imprinting,  agriculture,  as  a  replacement  for  aerosil  etc.  He  also
explained  that  aerogels  can  be  used  as  carriers  for  drug  delivery  and  addressed  the
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synthesis, properties and characterization of silica aerogels their field of pharmaceuticals
and  future  prospects.  This  method  can  be  used  as  an  alternative  to  the  micronization
procedure, used for these purposes at present time. Aerogels show great promise for use in
variety of technological areas where special structure and physical.
Mohammad  Alnaief [77] studied  various  applications  of  silica  aerogels.  Studied  were
extended  to  different  approaches  for  production of  micro spherical  aerogel  particles.  A
combination  of  sol-gel  process  with  the  emulsion  process  followed  by  supercritical
extraction  of  the  solvent  from gel-oil  dispersion  was  studied.  Micro  spherical  alginate
aerogel beads with exceptional high surface area were produced. The author used a novel
technique for the coating of aerogel materials an experimental spouted bed apparatus was
used, the process can be carried out in a batch process. The particle size from the nozzle
was measured using laser diffraction spectroscopy. The aerogels coated with Eutragit gave
a release of 20 percent lesser than the adsorbed one within 120 minutes, showing its nature
as pH sensitive drug release.  
M. Alnaief et al. [78] experimented on converting the aerogels which were before proved to
have  a  good  surface  area  and  biocompatibility  to  a  substance  which  could  hold  more
amount  of  drug.  This property was brought  about  by surface  functionalization with  an
amino group which provided the desired results. The modified aerogels offer more active
absorption sites for the drugs. it was possible to produce a transparent amino-functionalized
aerogel with a BET surface area of 960 m²/g, which is more than two times larger than that
obtained by other groups. By increasing the number of amino groups on the surface the
amount of drug loaded could also be improved. Here it is possible to design a carrier for a
particular drug or for controlled release of that drug in the media. 
Smirnova et al. [79] reported the feasibility of silica aerogels as oral drug delivery systems.
Silica  aerogels  were  loaded  with  several  drugs  by  adsorption  from  their  solutions  in
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supercritical CO2. It was demonstrated that for all three drugs investigated, high loading of
the aerogel  could be achieved. The loaded aerogels  were characterized by IR- and UV
spectroscopy and  X-ray diffraction  in  order  to  show that  no  degradation  of  the  drugs
occurred during the loading procedure. The release profiles of two drugs (ketoprofen and
griseofulvin) from loaded aerogels were measured. It was found that the drugs adsorbed on
hydrophilic silica aerogels dissolve faster than the corresponding crystalline drugs. This
fact can be explained by both an increase in the specific surface area of the drug adsorbed
on  the  aerogel  and  its  non-crystallinity  in  this  state.  The  influence  of  density  and
hydrophobicity of aerogels on both the adsorption and release of drugs were also studied.
Giuseppe  Caputo[80] studied supercritical  adsorption  coupled  with  the  high  adsorption
capacity of silica aerogel a new kind of delivery systems of poor water soluble drugs. In
order to overcome drawbacks of conventional techniques where the use of liquid solvents
can cause the fracture of aerogel porous structure, in this work a new adsorption process of
drugs from a supercritical mixture is proposed. Adsorption takes place from a fluid solution
of the drug in supercritical CO2 and ethanol as co-solvent. A fixed bed adsorption plant has
been developed to allow fast mixing of fluid phase and effective contact in the adsorption
column. The use of ethanol as co-solvent allows to overcome the limitation of supercritical
adsorption due to low solubility of many drugs in supercritical CO2. Adsorption isotherms
were measured for one-model substance, nimesulide, at 40°C, and breakthrough curve was
 experimentally obtained. The drug loading of the drug into silica aerogel was up to 9wt%.
The drug composite  was characterized using scanning electron microscopy,  and release
kinetics  of  the  adsorbed  drug  were  also  evaluated  by  in  vitro  dissolution  tests.  The
dissolution of nimesulide from loaded aerogel is much faster than dissolution of crystalline
nimesulide.  Around  80%  of  nimesulide  dissolves  from  the  aerogel  within  6  minutes,
 whereas dissolving 80% of the crystalline drug takes about 90min.
Garcia-Gonzalez et al.  [81] reported the use of  polysaccharides based aerogels carrier for
drug  delivery system.  The biodegradability  and  biocompatibility  of  these  biopolymers,
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coupled to the large variety of chemical functionalities, make them promising carriers for
drug  delivery systems.  Polysaccharide-based  aerogels  result  in  highly porous  (90–99%
porosities), lightweight (ρ=0.07–0.46g/cm3) drug carriers with high surface area (S =70–
680m2/g), able to provide enhanced drug bioavailability and drug loading capacity. This
review focuses on the state-of-the-art of the production of polysaccharide-based aerogels
with emphasis  on the influence of  processing parameters  on the resulting end material
properties. Case studies on polysaccharide-based aerogels from several sources and as well
as their behavior regarding drug loading capacity and release are described. 
Zeynep  Ulker and  Can  Erkey [82] in  their  review described  the  advances  in  “aerogel
science”  and  the  use  of  these  materials  in  pharmaceutical  sciences  for  drug  delivery
applications. Because of their high surface areas, high porosities and open pore structures
which can be tuned and controlled by manipulation of synthesis conditions, nanostructured
aerogels represent a promising class of materials for delivery of various drugs as well as
enzymes  and  proteins.  Along  with  biocompatible  inorganic  aerogels  and  biodegradable
organic aerogels, more complex systems such as surface functionalized aerogels, composite
aerogels  and  layered  aerogels  have  also  been  under  development  and  possess  huge
potential.  Emphasis  is  given  to  the  details  of  the  aerogel  synthesis  and  drug  loading
methods  as  well  as  the  influence  of  synthesis  parameters  and  loading methods on  the
adsorption and release of the drugs. Owing to their ability to increase the bioavailability of
low solubility drugs, to improve both their stability and their release kinetics, there are an
increasing  number  of  research  articles  concerning  aerogels  in  different  drug  delivery
applications. This review presents an up to date overview of the advances in all kinds of
aerogel based drug delivery systems which are currently under investigation. 
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3.1 AIM OF PRESENT WORK
Aspirin  currently finds  its  clinical  application as  an antiplateletic  drug.  For  this
purpose the amount of aspirin needed is continuous. Controlled release is preferred during
medication. The present work aims at developing a new drug carrier which is efficient than
the presently used. 
Aerogels  are  nanoporous  materials  with  extremely  low  bulk  density  and  high
specific  surface area. Usually they are produced following the sol-gel process followed by
suitable solvent removal. In  the  past  few  years  aerogels  have  drawn  an  increasingly
attention   in   different   scientific   and  industrial   applications.   Because   of   their
outstanding properties,  they  have  been  shown  to  be potential  drug  carrier  systems.
The  aim  of  this  work  is  to  extend  their  potential  in  pharmaceutical applications  by
filling  the  gaps  that  hinder  their  use  in  some  delivery  routes.  Three  different
strategies  were  implemented  to  achieve  this  goal:  (1)  production  of  microspherical
alumino-siloxane aerogel particles;  (2)  modifying  the  surface  functionality  of  the
aerogel   by   surface   functionalization  (3)  and  finally  loading  the  aspirin  drug   for
controlled release.
Controlling  the  dosage  quantity  in  the  drug  carrier  as  well  as  obtaining  a
specific  release mechanism of the loaded drug is of crucial importance in pharmaceutical
industry. Functionalization of aerogel surface with specific functional groups that modify
the  adsorption  capacity  of  the  loaded  drug  can  be  step  toward  controlling  the  dosage
quantity. Thiol and Amino functionalization was proposed as a model functionalization for
modifying the affinity of alumino-siloxane aerogels towards specific drugs. The main aim
of the work is to successfully modify aerogel without affecting the release properties of the
aerogels.
Multiporous microspheres are known to have a multi channeled walls which allows
the drug to entrap into it and get it released, this concept has to be studied.
The drug entrapment and the release profile on the novel alumino-siloxane aerogel
microspheres are to be studied and compare the results with the results given in literature.
This work further aims to design the formulation as a pH stimuli release; which selectively
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releases the drug only at the intestinal pH. This is brought about by the application of an
intermediate step of surface functionalization. Here the drug forms a weak bond with the
basic funtionalized outer pores and cleaves this bondage and would release in the intestine
(basic pH).
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3.2 PLAN OF WORK
PREFORMULATION STUDIES
• Determination of suitable composition for formation of spherical microspheres.
• IR studies to show there is no drug excipient irreversible interaction.
FORMULATION DEVELOPMENT
 Alumina Siloxane aerogel microspheres to be produced.
 Calcining the aerogels to remove all the organic groups.
 IR studies to carried out confirm the removal of organic.
 Drug loading capacity of the aerogel micro beads destainer shaker.
 Surface funtionalization to be done; to improve the drug loading capacity.
 Drug loading process to be carried and confirm with UV experiments the amount of drug loaded in 
the aerogel microspheres.
 Drug release studies to be carried out at both acidic and basic PBS.
EVALUATION STUDIES
• TGA
• FTIR
• PXRD
• Nitrogen Absorption Analysis BET
• SEM studies
• TEM studies
• UV Analysis
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4.  METHODOLOGY
4.1 Materials 
Table 4.1 Materials used
MATERIALS SOURCE
Aspirin (Acetyl salicylic acid) Acros Organics, Fisher Scientific, USA
Aluminum Isopropoxide (AIP) Sigma Aldrich, Purity>98%, USA
Aminopropyl trimethylsilane (APTMS) Sigma Aldrich, Purity>98%, USA
3- Mercaptopropyl trimethoxysilane (MPTMS) Sigma Aldrich, Purity>97%, USA
Tetraethylorthosilicate (TEOS) Sigma Aldrich, Purity>98%, USA
Polyvinyl alcohol(PVA) S D Fine chem. Ltd. India
Potassium dihydrogen phosphate S D Fine chem. Ltd. India
Disodium hydrogen phosphate S D Fine chem. Ltd. India
Isopropanol Merck, India
Methanol Merck, India
 4.2 Drug Profile[83]
          Chemical and physical data
Name                             : Aspirin 
Chemical Structure  
Chemical Name                     : 2-acetyloxybenzoicacid
                                                             Acetylsalicylic acid
Molecular formula                 : C9H8O4
Molecular mass                     : 180.157 g/mol
Category                               : Anti plateletic effect
Brand names                        :  Aspent Tab, Aspin 100 Enteric-Coated Tab           
Description                          :  White coarse powder, pungency of acetic acid 
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Solubility       : Soluble in alcohol sparingly soluble in water 3mg/mL   
                                               (20 °C)
Melting Point       : 136 °C
Density       : 1.40 g/cm3
Storage                   : Must be stored in a cool dry place
 Clinical Pharmacology
 (a)  Mechanism of Action: Platelets provide the initial hemostatic plug at sites of
vascular injury. Hence they participate in pathological thrombosis, which in turn lead to
myocardial  infarction.  Aspirin acts on eicosanoids(collective name for arachidonate and
related poly unsaturated fatty acids). Interference with the synthesis of eicosanoids is the
basis for the effects of many therapeutic agents.
In platelets, the major cyclooxygenase product is thromboxane A2, a labile inducer
of  platelet  aggregation  and  a  potent  vasoconstrictor.  Aspirin  blocks  production  of
thromboxane  A2 by  covalently  acetylating  the  serine  residue  near  the  active  site  of
cyclooxygenase,  the  enzyme  that  produces  the  cyclic  endoperoxide  precursor  of
thromboxane A2. As platelets do not synthesize new proteins hence the action of aspirin is
permanent one.
(b) Administration: Because of the potent and long lasting effect of low doses of
aspirin  on  platelet  function,  aspirin  is  used  in  the  treatment  or  prophylaxis  of  disease
associated  with  platelet  hyperaggregability,  such  as  coronary  artery  diseases  and  post
operative deep vein thrombisis. Oral administration is preferred
(c) Dosage:  The maximum effectiveness of such therapy appears to depend upon
selective blockade of TXA2 synthesis by platelets without preventing production of PGI2.
Selective antiplatelet action appears to be best achieved when the dose of aspirin is 40 to
80mg per day. Higher doses may inhibit PGI2 production. 
4.3. Excipient Profile
4.3a   Aluminum Isopropoxide[84]
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Molecular Formula                  : C9H21O3Al
Chemical Structure                   :
Molar Mass                              : 204.24 g/mol
Appearance                              : White solid
Density                                     :1.035 g/cm3, solid
Melting Point                           : 128-133oC
Solubility                                 : Soluble in water, isoproponol
Description:  Aluminium isopropoxide is usually described with the formula Al(O-
i-Pr)3,  where  i-Pr  is  the isopropyl group  (CH(CH3)2).  This  colourless  solid  is
useful reagent in  synthesis.  The  structure  of  this  compound is  complex,  possibly time-
dependent, and may depend on solvent.
       4.3b   Polyvinyl Alcohol (PVA)[85]
Synonym                  : Airvol, Elanol, Polyviol, Poval, PVA,Vinyl alcohol 
   polymer
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Chemical Name          : Ethenol, Homopolymer
Emperical Formula     : (C2H4O)n
Chemical Structure     :
Molecular Weight       : 30,000 – 2,00,000
Degree of                    : 1700 - 1800
Polymerization
Description :
Colour                      : White to cream coloured granular powder
Odour                       : Odourless
Melting Point            : 228oC for fully hydrolyzed grades
Refractive Index       : 1.49 – 1.53
         Solubility                   : Soluble in hot or cold water, slightly soluble in some    
                                       polyhydroxyl compounds, certain amines and amides. 
          Functional category   : Coating agent, Non-ionic surfactant. 
                                       
                  4.3c  Tetraethyl orthosilicate (TEOS)  [86]
Synonym                   : ethyl silicate, silicic acid tetra ethyl ester
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                       Molecular Fourmula :  SiC8H20O4
Chemical Structure    :
Molecular Mass        : 208.33 g mol-1
Density                  : 0.933g/ml at 20oC
Melting Point            : -77 oC
Solubility                  : Soluble in water but readily decomposes
 
                  4.3d   (3-Aminopropyl)trimethoxysilane (APTMS)
Synonym                  :   Aminopropyl trimethoxysilane
Chemical Structure   :
                                   
Boiling Point             : 91- 92oC 15 mmHg
Density                      : 1.027 g/ml at 25 oC
4.4 Instruments
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Table 4.2 Instruments used
4.4.1 Powder X-Ray Diffraction (XRD)
X-ray  crystallography  is  the  science  of  determining  the  arrangement  of  atoms
within a crystal from the manner in which a beam of X-rays is scattered from the electrons
within the crystal. In X-ray crystallographic analysis the pattern produced by the diffraction
of X-rays through the closely spaced lattice of atoms in a crystal  is  recorded and then
analyzed  to  reveal  the  nature  of  that  lattice.  Diffraction  effects  are  observed  when
electromagnetic radiation impinges on periodic structures with geometrical variations on
the length scale of the wavelength of the radiation. The inter atomic distances in crystals
and molecules amount to 0.15–0.4 nm which correspond in the electromagnetic spectrum
with the wavelength of x-rays having photon energies between 3 and 8 keV. Accordingly,
phenomena like constructive and destructive interference should become observable when
crystalline and molecular structures are exposed to x-rays. The X-ray diffraction pattern of
a pure substance is, therefore, like a fingerprint of the substance. The powder diffraction
method  is  thus  ideally  suited  for  characterization  and  identification  of  polycrystalline
phases.  The  spacing  in  the  crystal  lattice  can  be  determined  using  Bragg’s  law.  The
fundamental  equation  that  gives  a  relation  between  the  wavelength  of  X-rays  and  the
spacing in the crystal is the Bragg’s equation. Thus, the condition for a diffraction to occur
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Magnetic Stirrer Remi moters Ltd., Mumbai
Laboratory Oven Labline instrument, India
Vaccum Oven Amkette industries
High temperature Furnace Nabertherm, Germany
pH Meter Mettler Toledo
UV Spectrophotometer (UV) Shimadzu, Japan
FTIR Spectrophotometer (FTIR) Nicolet Magna-560
Powder X-Ray Diffraction (XRD) X’Pert Pro, Philips
Scanning Electron Microscopy (SEM) SEM-JEOL 5600 SL
Transmission Electron Microscopy 
(TEM)
JEOL, 200 CX, TEM
Thermo Gravimetric Analysis  (TGA) Mettler TG 50, Shimadzu, Kyoto
Nitrogen Sorption Measurements (BET) Micromeritics Gemini 2375
Destainer Shaker Scigenics Biotech, Orbitek
Optical Microscope Leica MZ 16 A
METHODOLOGY
is: 2d sinθ = nλ where, d is the inter planar distance, λ is the wavelength of X-ray, θ is the
angle of diffraction, n is the integer representing the order of the diffraction peak. The
diffraction peak is typically a plot of the scattering intensity vs. the scattering angle 2θ. The
peak positions, intensities, peak width and peak shape all provide important information
about the structure of the material. A sharper peak with high scattering intensity indicates
that the sample has good crystallanity. The peaks in an X-ray diffraction pattern are also
related to the unit cell dimensions.
4.4.2. Scanning Electron Microscopy (SEM)
A scanning electron microscope (SEM) is a type of electron microscope that images
a sample by scanning it with a beam of  electrons in a  raster scan pattern. The electrons
interact with the atoms that make up the sample producing signals that contain information
about the sample's surface topography, composition, and other properties such as electrical
conductivity.  These  signals  include  secondary  electrons,  back  scattered  electrons,
characteristic X-rays and light. SEM is a powerful method for the investigation of surface
structures of. This technique provides a large depth of field, which means, the area of the
sample that can be viewed in focus at the same time is actually quite large. SEM has also
the advantage that the range of magnification is relatively wide allowing the investigator to
easily focus in on an area of interest on a specimen that was initially scanned at a lower
magnification.  The  basic  steps  involved  in  SEM  sample  preparation  include  surface
cleaning, stabilizing the sample with a fixative, rinsing, dehydrating, drying, mounting the
specimen on a  metal  holder,  and coating the sample with  a  layer  of  a  material  that  is
electrically conductive.
In  a typical  SEM, electrons are thermionically emitted from a tungsten filament
cathode and are accelerated towards an anode. The electron beam, which typically has an
energy ranging from a few hundred eV to 40eV, is focused by one or two condenser lenses
into a beam. The beam passes through pairs of scanning coils or pairs of deflector plates in
the electron column, typically in the final lens, which deflect the beam horizontally and
vertically so that it scans in a raster fashion over a rectangular area of the sample surface.
When the primary electron beam interacts with the sample, the electrons lose energy by
repeated scattering and absorption within the specimen. The energy exchange between the
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electron beam and the sample results in the reflection of high-energy electrons by emission
of secondary electrons and the emission of electromagnetic radiation which can be detected
to produce an image.
Microstructure  analyses  of  alumina  aerogel  beads  with  each  of  the  DCCAs
(calcined) were taken. Studs were polished initially with fine graded carbon paper  and
carbon  tape  is  fixed  on  it.  The  beads  were  mounted  on  the  studs  and  pasted  with  a
conductive material. In our present study we used Scanning Electron Microscope  (SEM-
JEOL 5600 SL), for the analyzing the morphology and meso porosity.
4.4.3. Transmission Electron Microscopy (TEM)
Transmission  electron  microscopy (TEM) is  a  microscopy technique  whereby a
beam  of  electrons is  transmitted  through  an  ultra  thin  specimen,  interacting  with  the
specimen as it passes through. An image is formed from the interaction of the electrons
transmitted through the specimen; the image is magnified and  focused onto an imaging
device, such as a fluorescent screen, on a layer of photographic film, or to be detected by a
sensor such as a CCD camera.
In  TEM electrons  are  accelerated  to  100  KeV or  higher  (up  to  1MeV),  When
electrons are accelerated up to high energy levels (few hundred KeV) and focused on a
material,  they  can  scatter  or  backscatter  elastically  or  inelastically,  or  produce  many
interactions, source of different signals such as X-rays, Auger electrons or light Figure 4.1.
The beam of  electrons transmitted through an ultra thin specimen,  interacting with  the
specimen as it passes through. The scattering processes experienced by electrons during
their passage through the specimen determine the kind of information obtained. An image
is  formed  from  the  interaction  of  the  electron  transmitted  through  the  specimen  are
magnified and focused onto an imaging device, such as a fluorescent screen, on a layer of
photographic  film,  or  to  be  detected  by  a  sensor.  TEM  are  capable  of  imaging  at  a
significantly  higher  resolution  than  light  microscope,  owing  to  the  small  de  Broglie
wavelength of electrons. This enables the instrument’s user to examine fine details- even as
small  as  a  single  column of  atoms,  which is  tens  of  thousands times smaller  than the
smallest resolvable object in a light microscope.
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Figure 4.1 Electron scattering in conventional TEM
At smaller magnifications, TEM image contrast is due to absorption of electrons in
the material due to the thickness and composition of material. At higher magnifications
complex wave interactions modulate the intensity of the image, requiring expert analysis of
observed images.  Alternate modes of  use allow for the TEM to observe modulation in
chemical  identity,  crystal  orientation,  electronic  structure  and  sample  induced  electron
phase shift as well as the regular absorption based imaging. In the case of a crystalline
material, electron diffraction will not only occur at specific angles, which are characteristic
for the crystal structure present. As a result, a diffraction pattern of the irradiated area is
created  that  can  projected  onto  the  CCD camera.  In  this  way  electron  diffraction  can
provide  crystallographic  information  from  thin  films,  bulk  material  as  well  as  from
nanometer  sized  particles.  The  greatest  advantages  that  TEM  offers  are  the  high
magnification ranging from 50 to 106 and its ability to provide both image and diffraction
information from a single sample. For the present study, Transmission electron microscopy
images were recorded using a JEOL, 200 CX, TEM.
4.4.4 Fourier Transform Infrared Spectroscopy (FTIR)
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Fourier  transform infrared  spectroscopy (FTIR)  is  a  technique which is  used  to
obtain an infrared spectrum of absorption, emission, photoconductivity or Raman scattering
of a solid, liquid or gas. This confers a significant advantage over a dispersive spectrometer
which measures intensity over a narrow range of wavelengths at a time. FTIR has made
dispersive infrared spectrometers all but obsolete (except sometimes in the near infrared),
opening up new applications of infrared spectroscopy.  Fourier Transform Infrared (FTIR)
spectrometry  was  developed  in  order  to  overcome  the  limitations  encountered  with
dispersive instruments. The main difficulty was the slow scanning process. A method for
measuring  all  of  the  infrared  frequencies  simultaneously,  rather  than  individually,  was
needed. A solution was developed which employed a very simple optical device called an
interferometer. The interferometer produces a unique type of signal which has all of the
infrared frequencies “encoded” into it. The signal can be measured very quickly, usually on
the order of one second or so. Thus, the time element per sample is reduced to a matter of a
few seconds rather than several minutes. The development of reliable FTIR instrumentation
and strong computerized data-processing capabilities has greatly improved the performance
of quantitative IR work. The basis for quantitative analysis of absorption spectrometry is
the Bouguer-Beer-Lambert law,
                
                                                             A = abc
Deviations from Beer’s law occur more often in infrared spectroscopy. However,
coupling of  the advancement  of  computerized  FTIR instrumentation  can  make FTIR a
viable option for reliable quantitative analysis.
FTIR  analysis  provides  information  about  the  chemical  bonding  or  molecular
structure of materials, whether organic or inorganic. The technique works on the fact that
bonds and groups of bonds vibrate at characteristic frequencies. A molecule that is exposed
to infrared  rays  absorbs  infrared  energy at  frequencies  which  are  characteristic  to  that
molecule.  The FTIR spectrum is equivalent  to the “fingerprint” of the material.  During
FTIR analysis, a spot on the specimen is subjected to a modulated IR beam. The resulting
FTIR spectral pattern is then analyzed and matched with known signatures of identified
materials in the FTIR library.  
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4.4.5 Thermo Gravimetric Analysis (TGA)
Thermo gravimetric analysis (TGA) is an analytical technique used to determine a
material’s  thermal  stability  and  its  fraction  of  volatile  components  by  monitoring  the
weight change that occurs as a specimen is heated. It relies on a high degree of precision in
three measurements: weight, temperature, and temperature change. As many weight loss
curves look similar, the weight loss curve may require transformation before results may be
interpreted. A derivative weight loss curve can be used to tell the point at which weight loss
is  apparent.  It  is  commonly employed to determine degradation temperatures,  absorbed
moisture content of materials, the level of inorganic and organic components in materials,
decomposition points of explosives and solvent residues. 
 The analyzer usually consists of a high-precision balance with a pan loaded with
the sample. The sample is placed in a small electrically heated oven with a thermocouple to
accurately measure  the  temperature.  The  maximum temperature  is  selected  so  that  the
specimen weight is  stable at  the end of  the experiment,  implying that  all  the chemical
reactions are completed (i.e., all of the carbon is burnt off leaving behind metal oxides).
The atmosphere may be purged with an inert gas to prevent oxidation or other undesired
reactions. Analysis is carried out by raising the temperature gradually and plotting weight
against temperature.
4.4.6 Nitrogen Sorption Measurements (BET Surface area analysis)
Surface area and porosity nature was studied by standard N2 adsorption technique
using  surface  area  analyzer,  after  degassing  the  samples  at  200  °C  for  2  h. Nitrogen
sorption  measurements  are  the  most  common  methods  for  the  determination  of
porosity related parameters such as specific surface area or pore radii. Nitrogen is cheap, it
is not very reactive and the main interaction with the surface is given by physisorption. For
a  typical  measurement,  the  sample  is  evacuated  at  elevated  temperatures  to  remove
adsorbed water.  For the measurement the sample is  cooled down to the temperature of
liquid nitrogen of 77 K. Gaseous nitrogen is then added step by step in small portions.
Keeping the system in  equilibrium  between  the  adsorbed  gas  and  the  free  gas,  the
pressure  in  the  respective volume  will  change.  A  plot  of  the  adsorbed  volume  in
dependence  of  the  relative  pressure p/po,  where p denotes the equilibrium pressure and
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po  the saturation vapor pressure,  gives  the so-called adsorption isotherm, which slope
strongly depends on the nature of the sample. In Figure 4.2 typical adsorption isotherms are
shown:
Figure 4.2 IUPAC classification of sorption isotherms
Following  the  IUPAC  classification  of   sorption  data,   the  Type  I   thus
identifies  a microporous  material  due  to  the  steep  increase  of  the  adsorbed  volume
at  low  relative  pressures.  A  Type  II  isotherm  is  observed  for  non-  or  macroporous
materials.   The  point  B  (marked  with  an  arrow  in  Figure  4.2)  denotes  the  onset  of
multilayer adsorption. Type III is  obtained  for  a  weak  interaction  of  the  gas  with  the
surface.  Type  V  isotherms  are  very  uncommon, but observed for certain systems like
graphite, which shows a weak interaction  with  water  molecules  together  with  some
porosity.  At  higher  relative  pressures,  capillary  condensation may be observed, which
means that inside the pores liquid gas is formed even  before  the  saturation  pressure  is
reached.  The  capillary  condensation  strongly  depends  on  the  pore  diameter  and  for
small  diameters  condensation  is  observed  earlier.  Type VI is observed for layer by layer
adsorption on a uniform non-porous surface. Finally, Type IV is the typical isotherm one
would observe for  a  mesostructured material.
4.4.7 Ultraviolet-Visible Spectroscopy (UV)
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 Absorption of light by solution is one of the oldest and still one of the more useful
instrumental  methods.  The  wavelength  of  light  that  a  compound  will  absorb  is
characteristic of its chemical structure. Specific regions of the electromagnetic spectrum
are absorbed by exciting specific types of molecular and atomic motion to higher energy
levels. Absorption of visible and ultraviolet (UV) radiation is associated with excitation of
electrons, in both atoms and molecules, to higher energy states. All molecules will undergo
electronic excitation following absorption of light, but for most molecules very high energy
radiation  (in  the  vacuum  ultraviolet,  <200  nm)  is  required.  For  molecules  containing
conjugated  electron  systems  however,  light  in  the  UV-visible  region  is  adequate  (e.g.,
benzene  absorbs  in  the  260  nm  region).  As  the  degree  of  conjugation  increases,  the
spectrum  shifts  to  lower  energy.  Thus  naphthalene  absorbs  light  up  to  300  nm,  and
anthracene  absorbs  to  about  400  nm.  Because  absorption  spectra  are  characteristic  of
molecular  structure,  they  can  be  used  to  qualitatively  identify  atomic  and  molecular
species.
Ultraviolet–visible  spectroscopy  and  near-infrared  or  ultraviolet-visible
spectrophotometry (UV-Vis  or  UV/Vis) refers  to absorption spectroscopy or  reflectance
spectroscopy in the ultraviolet-visible spectral region. This means it uses light in the visible
and adjacent (near-UV (NIR)) ranges. The absorption or reflectance in the visible range
directly  affects  the  perceived  color  of  the  chemicals  involved.  In  this  region  of  the
electromagneticspectrum,  molecules  undergo  electronic  transitions.  This  technique  is
complementary to fluorescence spectroscopy,  in that  fluorescence deals with  transitions
from the excited state to the ground state, while absorption measures transitions from the
ground state to the excited state. 
The amount of light, I, transmitted through a solution of an absorbing chemical in a
transparent solvent can be related to its concentration by Beers Law:
                                                        -logI/Io= A= ελbc 
Where I0 is the incident light intensity, A is the absorbance (a defined quantity, also
referred to as the optical density, or OD), b is the cell path length in cm, c is the solution
concentration in moles/liter, and ελ is the molar absorptivity.
The  instrument  used  in  ultraviolet-visible  spectroscopy  is  called  a  UV/vis
spectrophotometer.  It  measures  the intensity of  light  passing through a sample (I),  and
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compares it to the intensity of light before it passes through the sample (I0). The ratio I/IO is
called the transmittance, and is usually expressed as a percentage (%T). The absorbance, A
is based on the transmittance:
A= -log (%T /100%)
 A spectrophotometer can be either single beam or double beam. In a single beam
instrument all of the light passes through the sample cell. I0 must be measured by removing
the sample. In a double beam instrument, the light is split into two beams before it reaches
the sample. One beam is used as the reference; the other beam passes through the sample.
Some double  beam instruments  have  two detectors  (photodiodes),  and  the  sample  and
reference  beam measured  at  the  same  time.  In  other  instruments  the  two  beams  pass
through  the  beam chopper,  which  blocks  one  beam at  a  time.  The  detector  alternates
between measuring the sample beam and the reference beam. The resulting spectrum is
presented as a graph of absorbance (A) versus wavelength (λ).
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5. EXPERIMENTAL INVESTIGATION
5.1 Method of preparation of alumino-siloxane aerogel microspheres
Alumino-siloxane  aerogel  microspheres  were  prepared  by  sol-gel  method  via
ambient pressure drying. The raw material for the synthesis of alumina sol was AIP. AIP
was  a  cheaper  alkoxide  with  similar  property  that  of  aluminum  tertiary  or  secondary
butoxide.  Alumina  sol  of  1M  concentration  was  prepared  by  the  hydrolysis  and
condensation  reaction  of  AIP  by  modified  Yoldas  process[87]  . In  this  experiment  the
precursor AIP was first hydrolyzed in water at 80-85 oC. The initial hydrolysis temperature
of 80 °C was chosen because it is the highest temperature compatible with avoiding violent
boiling caused by the exothermic hydrolysis and condensation reactions. After hydrolysis
and condensation, acid was added to cause peptization and the resultant sol was refluxed
overnight  for  more than 12 hrs  at  95-100o  C to form a clear,  stable,  colloidal  sol.  The
reaction is given by the equation
   Al(O-C3H7)3 (l) + (n+2) H2O(l) +HCl (aq)                 AlO(OH).nH2O(s) + 3C3H7OH(g)
To the hydrolyzed alumina sol containing 4g Al2O3, weighed amount of PVA was
added  and  stirred  for  30  min.  Subsequently,  weighed  amount  of  3-Aminopropyl
trimethoxysilane was added drop wise. The resultant alumina/silanes stiff gel was again
peptized by adding nitric acid up by adjusting the pH to 3 and stirred for 1h to obtain sol -
gel mixture of alumino-siloxane. 
The partially gelled sol was then sprayed through the syringe. The sol droplet passes
through an oil  layer  as shown in experimental  set  in Figure  5.1.  Various  compositions
selected for the experiment are given in Table 5.1. Spherical wet gel microspheres were
formed due to surface tension. The wet gel microspheres then fell into an ammonia solution
placed  right  underneath  the  oil.  After  aging  in  ammonia  solution  for  about  1  hr,  the
microspheres  are  then  withdrawn from ammonia solution,  carefully sieved  and washed
with water and alcohol to eliminate oil and ammonia residues. The microspheres were then
washed with isopropanol several times within 24 hours so as to remove water from pores.
During washing process  the beads were kept at  50o C,  this  was followed by aging the
samples  in  TEOS solution for  48 hours  at  50o C and  the  final  solvent  exchange  with
isopropanol. The microspheres were then dried in tightly closed containers at 50o C.
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Fig 5.1 Schematic representation of alumino- siloxane microspheres formation
Table 5.1 Composition of samples prepared
Sample
code
H2O/AIP
(molar ratio)
APTMS/AIP
(molar ratio)
PVA
(wt %)
Viscosity of the
gel (Pa.s) Shape
Shrinkage
(%)
A1 60 0.38 5.0 7.81 Irregular 13
A2 70 0.38 5.0 3.41 spherical 15
A3 80 0.38 5.0 2.14 spherical 18
A4 90 0.38 5.0 1.40 spherical 25
A5 100 0.38 5.0 1.23 spherical 36
A6 80 0.38 0.0 2.45 Cracked ----
A7 80 0.38 2.0 2.75 spherical 14
A8 80 0.38 3.0 2.40 spherical 15
A9 80 0.38 5.0 2.54 spherical 15
A10 80 0.38 8.0 2.98 Cracked -----
A11 80 0.09 5.0 2.56 spherical 13
A12 80 0.19 5.0 2.74 spherical 14
A13 80 0.38 5.0 2.43 spherical 16
A14 80 0.56 5.0 2.12 spherical 16
A15 80 0.75 5.0 2.45 spherical 15
A16 80 0.95 5.0 3.00 Cracked ----
 
The best formulated selected out of the above formulation was subjected to further
studies based on the shrinkage, shape and density of the samples. The above samples were
further calcined to remove the organic template at 600 °C. Samples A11, A12, A13, A14
and A15 calcined at 600 °C are denoted as A111, A121, A131, A141 and A151 respectively.
The samples A111, A121, A131, A141 and A151 were selected for further studies, for drug
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loading. A151 sample found to have maximum drug loading capacity. (Detailed explanation
is given in chapter 6).  From the literature it  is  clear that  functionalization can improve
loading  of  drug.  To  prepare  functionalized  aerogel  microspheres  by  post-synthesis,
maximum drug loaded sample (A151) were selected and following procedure adopted for
loading.
5.2 Surface functionalization of aerogel microspheres with organotrialkoxy silane    
         (APTMS and MPTMS)
Prior  to  surface  modification,  aerogel  microspheres  (A15) dried  at  110° C in  a
vacuum oven for 15 h to remove moisture adsorbed at the surface.  0.3g of samples was
then dispersed in dry toluene. 1, 2, 3 ml of silane (APTMS /MPTMS) was added to the
mixture and was refluxed for 20 h under argon atmosphere. Dry toluene was used in order
to prevent homo polycondensation of silane. This also promotes local hydrolysis of silane
methoxy (Si–O–Me) groups to Si–OH, which then undergo condensation with –OH groups
at the closest proximity of the surface and pores of microspheres. The samples were then
washed several times with toluene to remove the unreacted siloxane moieties. The samples
were dried under vacuum at 110 °C for 3 h to remove residual toluene.
5.3 Loading of aspirin drug
To load aerogel microspheres with aspirin, 50 mg of the aerogel samples was added
to 20 mL of aspirin in methanol solution (2 mg/mL) and soaked for 3 days under stirring
until  the  concentration  of  the  solution  did  not  significantly  change;  this  was  done  by
monitoring  the  aspirin  concentration  using  a  Shimadzu  UV  spectrophotometer  at  a
wavelength  of  296 nm. The amount  of  drug loaded  onto the  samples  was  determined
according  to  the  change  of  concentration  before  and  after  soaking.  The  samples  were
quickly and thoroughly washed with methanol and dried under vacuum. 
5.4 Preparation of Phosphate buffered saline (PBS)
For pH -7.4 [88]
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Add 250.0 ml of 0.2 M potassium dihydrogen phosphate R to 393.4 ml of 0.1 M
sodium hydroxide.
For pH -2 [88]
Dissolve  8.95  g  of  disodium  hydrogen  phosphate  R  and  3.40  g  of  potassium
dihydrogen phosphate R in  water  R and dilute  to 1000.0 ml with the same solvent.  If
necessary adjust the pH (2.2.3) with phosphoric acid R.
For pH- 9 [88]
Dissolve 1.74 g of potassium dihydrogen phosphate R in 80 ml of water R, adjust
the pH (2.2.3) with 1 M potassium hydroxide and dilute to 100.0 ml with water R.
5.5 In Vitro Drug Release Studies.
The release profiles of  model  drugs  were determined by soaking 50mg of  drug
loaded  sample  in  20  mL of  PBS  (pH  2,  7.4,  9.)  under  shaking  150  rpm,  at  room
temperature. Predetermined time, replaced by fresh medium, and spectrophotometrically
analyzed at wavelength 296 nm.
5.6 Material Characterization Techniques  
The following characterization techniques provide information on the effects of the
synthesis process on the aerogel, along with the surface and bulk properties of the row and
functionalized aerogels microspheres.
(a) Viscosity measurements
The  rheological  measurements  of  the  alumino-siloxane  gels  were  examined  in
cylinder and bob method using a stress controlled Anton Paar Rheo Viscometer by the
cyclic application and release of shear force. The measurements started 1 h after the gels
had formed.
(b) Thermo Gravimetric Analysis (TGA)  
During  thermal  analysis,  material  samples  gain  or  lose  weight  due  to  thermal
events,  such  as  decomposition,  oxidation  or  reactions  taking  place  at  particular
temperatures.  Thermogravimetric  analysis  (TGA)  is  the  thermal  analysis  of  a  sample
whereby the mass of the sample is measured as a function of temperature and time under
controlled temperature in a chosen environment (e.g. air, nitrogen). TGA is used to obtain
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characteristic qualitative (composition) as well as quantitative (amount) information of a
sample from a thermogram. Thermograms show stable regions and locations  of weight
changes  which  are  usually  specific  to  various  components  of  the  sample  undergoing
thermal events. The size of the weight change can be used to obtain quantitative analysis of
the thermal event such as organic content of a sample. 
Thermogravimetric analyses (Mettler TG 50 (Shimadzu, Kyoto) in air) were carried
out to detect the decomposition temperature of the organic moieties grafted on the porous
aerogel  microspheres.  Samples  were  heated  from room temperature  to  1000  ºC  at  the
heating rate of 10 ºC /min.
(c) Fourier Transform Infrared Spectroscopy (FTIR)  
FTIR instruments use an interferometer to obtain an interferogram (i.e. interference
pattern  obtained  from  reflected  beams),  which  is  then  passed  through  the  sample;
information  at  every  wavelength  is  read  by the  detector  during  rapid  scanning  of  the
interferometer.  FTIR  is  used  to  obtain  absorption  spectra  of  a  compound which  show
unique reflections of the molecular structure of that compound. This information can be
used to identify unknown samples, to analyze sample for composition and also to quantify
sample components. 
  The FT-IR spectroscopic measurements row and functionalized materials were
carried out using IR Prestige-21 Shimadzu spectrophotometer. The spectra were recorded
as KBr pellets of the samples in the wave number range 400-4000 cm-1 with a resolution of
4 cm-1 in transmittance mode.
(d) Powder X-Ray Diffraction (PXRD)  
Powder X-ray diffraction occurs when X-rays and electrons of atoms interact. When
the x-rays hit the electrons some are scattered (diffracted). Depending on the arrangement
of atoms in a sample, interference of two diffracted rays can be constructive (i.e., their path
difference  equals  an  integral  number  of  the  incident  wavelength)  (detailed  explanation
given in chapter 4; section 4.4.1.)
In this work X’Pert Pro, Philips powder X-ray diffraction system with Cu-Kα  radiation
(λ=1.54056o  A) was used. The X-ray scans are performed between 2θ values 10o and 70o
for the phase identification.
(e) Nitrogen Adsorption Analysis  
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The  physical  adsorption  (physisorption)  of  gases  on  porous  aerogel  surfaces  is
useful in the characterization of porous nature of solid[89]. A gas (e.g. nitrogen) adsorption
isotherm, a plot of relative pressure against volume of gas adsorbed, is used to estimate the
type of pores in the solid material, the size of the pores, the total surface area of the solid
material and the pore volume. (detailed explanation given in chapter 4; section 4.4.6.)
N2 adsorption-desorption analysis  was done using ASAP 2010C (Micromeritics,
USA) system, at liquid N2 temperature (77K) degassing at appropriate temperature for
sufficient time to clean the surface of the adsorbents via a multipoint BET method using the
adsorption data in the relative pressure (P/P0) range of 0.09-0.10.. The Brunauer Emmett
Teller (BET) method was utilized to calculate the specific surface areas.  All the samples
were degassed at 200 °C for 2 h prior to BET measurements. Desorption isotherm was
used  to  determine  the  pore-size  distribution  using  the  Barret-Joyner-Halender  (BJH)
method, assuming a cylindrical pore model.
(f) Scanning Electron Microscope 
  The scanning electron microscope (SEM) uses a focused beam of high-energy
electrons to generate a variety of signals at the surface of solid specimens. The signals that
derive from electron-sample interactions  reveal  information about the sample including
external  morphology  (texture),  chemical  composition,  and  crystalline  structure  and
orientation of materials making up the sample. In most applications, data are collected over
a selected area of the surface of the sample, and a 2-dimensional image is generated that
displays spatial variations in these properties. Areas ranging from approximately 1 cm to 5
microns in width can be imaged in a scanning mode using conventional SEM techniques
(magnification ranging from 20X to approximately 30,000X, spatial resolution of 50 to 100
nm). 
  The surface morphology of composites was observed by using ZEISS EVO 18
Special Edition Scanning Electron Microscope (SEM), operated at 20 kV. Pinch of samples
were added to test tube with appropriate solvent, and sonicated, until uniform dispersed
solution was obtained. One layer of this solution poured in to the aluminum stub and dried
at overnight. This sample was used for the analysis of SEM.
(g) Transmission Electron Microscopy (TEM)  
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Transmission electron  microscope  (TEM) is  used  to  greatly  magnify specimens
using a beam of electrons. The resolution of 100-keV electron is on the order of an atomic
size  (~  0.3  nm)  as  compared  to  that  of  a  light  microscope  (~300  nm)[90]. The  light
microscope  can  only  magnify  images  about  1000  times  but  images  on  an  electron
microscope can be highly magnified to see atomic details in the sample. This is because the
resolving power (minimum distance between two distinct objects) is directly proportional
to the wavelength of illumination. The wavelength of electrons at 60 kV is about 5 ×10-3
nm compared to that of visible light (400–800 nm)[91]  . Images in TEM are magnified by
electromagnetic lenses which control the electrons that pass through the sample to generate
extremely fine structural detail of the sample. Based on the thickness of the sample, some
of the electrons are scattered. However, at the bottom of the microscope column electrons
that pass through the electron transparent sections of the sample are focused on a viewing
screen.  A range  of  signals  are  detected  in  transmission  electron  microscopes  to  obtain
images, diffraction patterns, chemical information and other kinds of spectra.
  Interior  morphological  structure  of  samples  were  evaluated  by  transmission
electron-microscope was done by recorded using FEI Tecnai 30G2S- TWIN Transmission
electron microscope (TEM) operated at an accelerating voltage of 300kV. Pinch of samples
were added to test tube with appropriate solvent, and sonicated until uniform dispersed
solution was obtained. One drop of this solution poured in to the glossy carbon grid and
dried at overnight. This sample was used for the analysis of TEM.
(h)  Ultraviolet-Visible Spectroscopy (UV)
Concentration of aspirin in the solution before and after equilibrium was analyzed
by UV–visible spectroscopy at λmax = 296 nm, equipped with a quartz cell having a path
length of 1cm.
The concentration of  drug solution was monitored by UV/Vis spectrophotometer
(Shimadzu UV 240 IPC). While  the  measurements  wavelength  interval  was  adjust
between  200  and  500  nm  and  absorption  peaks  for  aspirin  were  detected  in  296
nm.
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6. RESULTS AND DISCUSSION
The various results obtained in the project work are presented in this chapter. The
results of thermal stability, phase purity, chemical bonding, surface and pore features, and
morphology of the prepared aerogels have been presented. The drug loading and release
studies are discussed. 
6.1 Textural and Structural Analysis of Aerogel Microspheres
6.1.1 Thermal analysis
The shapes of the TGA curves obtained by the heat treatment in oxygen atmosphere
of five set of samples A11, A12, A13, A14 and A15 are displayed, Figure 6.1, as a whole
resemble closely with each other. The main changes during thermal analysis of the samples
correspond to the removal of the organic matrix. As revealed from the TGA, alumino-
siloxane aerogels degrades mainly by a three-stage process, and it is destroyed completely
at 600 °C. Because the alumina-based material is readily bibulous, some dehydration of gel
(100-150 °C) is still visible in the TGA curves. 
Figure 6.1. TGA curves of the aerogel samples under oxygen at a heating rate of 10
◦C/min.
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The second weight loss occurs for 250-300 °C with a weight loss of 5%, due to the
degradation of  organic  attached  in  inorganic,  and  probably due  to  the  release  of  large
amount  of  organic  oxygenated  groups  formed  as  a  result  of  the  hydrolysis  process
undergone by the alkoxides which can remain in the organic matrix, either merely trapped
inside or even linked to it. The third happens at 460-600 °C with a weight loss of 35%, due
to  the  decomposition  of  complete  organic  structures  leaving  alumino-siloxane  Al-O-Si
network  in  the  aerogel  structure.  Complete  organic removal  with  phase  stable Al-O-Si
network obtained after 600 °C.
6.1.2 Phase analysis
Phase  transformation  of  the  as  prepared  aerogel  microsphere  and  heat  treated
microspheres at 600 °C was investigated and the results are shown in Figure 6.2 Sample
without  heat  treatment/calcination  have  a  well  developed  boehmite  structure  with  an
amorphous  nature  of  silica  and  carbon  in  the  skeleton.  On  heat  treatment  at  600°  C
boehmite  is  converted  to  -Al2O3.  The  peak  at  20-30  range  showed  a  broadening  and
amorphous nature due to the presence of alumino-siloxane skeleton in the aerogel network. 
Figure 6.2 X-ray diffraction (XRD) patterns of A15 and A151 samples.
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6.1.3 Structural analysis
Figure  6.3  shows  FTIR  spectra  of  A151 and  A15,  with  and  without  heat
treatment/calcination. The FTIR spectrum clearly shows the respective band positions for
Al-O and Si-O bonds in the system. In general Al-O and Si-O related vibrations mostly
appear in the wavelength region 1200-400 cm-1. For A15 sample the peaks at 3310 cm-1,
1620 cm-1, and 1078 cm-1 were assigned to stretching, bending mode of adsorbed water and
deformation mode of –OH group, respectively. The deformation mode of free amino group
can be found at 1514 cm-1. The vibration bands at 2937 cm-1 is attributed to C-H symmetric
vibration.  Again in A15 bands at 3094 cm-1 and 3303 cm-1  is assigned to the stretching
vibration of N-H from APTMS. This is shows the presence amine functionalityA15. The
broadened peak at 1020 cm-1 in A151 is due to the overlap of Al-O-Si, and Si-O-Si bonding
in sol gel  reaction, which appears at 1000-1200 cm-1  range.  A151  shows only the major
peaks Al-O-Si, and Si-O-Si bonding in its structure, all the peaks due to amine and organic
functionality are eliminated after heat treatment at 600°C. All the major peaks are shown in
Table 6.1. 
Figure 6.3 FTIR spectra of A15 and A151 alumino- siloxane aerogels.
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Table 6.1 Bands assigned to various functional groups in FTIR spectra of A15 and A151
Group
assigned to
A15
Bands (cm-
1) assigned
to A15
Group
assigned to
A151
Bands (cm-1)
assigned to A151
Si-O-Si
stretching
Si-O-Si
bending
Si-O bending
Al-O-Si
C-H
symmetric
N-H
stretching
-OH
-OH of Al-
OH
1078
773
476
923
2927
3094,3303
~3500-
3300
1620
Si-O-Si
stretching
Si-O-Si
bending
Si-O
bending
Al-O-Si
-OH
-OH of Al-
OH
1087
799
479
913
~3500-3300
1628
6.1.4 Morphology and microstructure analysis
Scanning electron microscopy (SEM) and transmission electron microscopy (TEM)
was employed to further understand the microstructure of the alumino-siloxane aerogels
and are shown in Figure 6.4 Both SEM Figure 6.4 (b) and TEM Figure 6.4 (c) of the
alumino-siloxane aerogels after heat treatment, exhibited typical porous network structures.
The  framework  of  aerogels,  achieved  after  the  thermal  treatment,  was  uniform  and
interconnected. The TEM image (c) showed that heat treated aerogels at 600°C exhibited
randomly interconnected networks made up of nanometer-sized fibrous γ-Al2O3. Figure 6.4
(a) photograph of alumino-siloxane are shown.
Figure 6.4 (a) Photograph (c) SEM (d) TEM of alumino-siloxane aerogel microspheres
(A151)
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6.1.5 Textural properties 
N2 adsorption–desorption isotherms were performed to further explain the porous
structure  of  aerogel  microspheres.  As  shown in  Figure  6.5,  isotherms are  identified  as
resembles a type IV and type II curve, according to the IUPAC classification, with a sharp
upturn in the high relative pressure, which indicates liquid condensation associated with the
presence of large mesopores and macropores. The hysteresis loop of the aerogel samples
falls within the H3 and H4 categories, which is typical of slit-type pores generated from the
interparticle porosity of fiber-like morphology. Figure 6.6 shows the pore size distribution
of  alumino-siloxane  aerogel  microspheres.  The  pore  size  was  calculated  from  the
desorption branch of the nitrogen isotherm with a BJH model. Pore parameters A111, A121,
A131, A141 and A151 samples at 600 °C are listed in Table 6.2. The BET surface areas and
average diameter of pores decreased from 347 to 261m2/g and 9.7 to 5.0 nm respectively. 
Figure 6.5 N2 adsorption–desorption isotherms of alumino-siloxane aerogel 
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Figure 6.6 Pore size distribution curves of different thermal treated aerogel microspheres.
Table 6.2 Physical characteristics of alumino-siloxane aerogel microspheres
Samples
BET /Langmuir
surface area (m2/g)
Total  pore
volume
(cm3/g)
Pore
diameter
(nm)
A111 347/561 0.4952 9.7 
A121 321/521 0.4312 7.5 
A131 280/449 0.3654 6.7 
A141 234/477 0.3214 5.6 
A151 261/418 0.3124 5.0
6.2 Aspirin Loading and Release
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6.2.1 Standard Curve for Aspirin API
Table 6.3 Absorbance measured for preparation of standard curve
Concentration mg of aspirin
0.04 0.08
0.08 0.16
0.12 0.24
0.16 0.32
0.20 0.40
0.0 0.1 0.2 0.3 0.4
0.0
0.4
0.8
1.2
1.6
A
B
S
O
R
B
A
N
C
E
mg/ml of ASPIRIN
 Standard Curve
 Linear Fit of Standard Curve
Equation y = a + b*x
Adj. R-Square 0.99771
Value Standard Error
C Intercept 0.0069 0.02212
C Slope 4.26214 0.09131
Figure 6.7 Standard curve for aspirin by UV spectroscopy method
6.2.2 Loading aerogel microspheres with aspirin. 
Table 6.4 Loading amount of aspirin on different aerogel microspheres.
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Sample code Amount of Aspirin loaded to
50 mg microspheres (mg)
%
Loading
Stock solution - -
A111 4.8 12
A121 5.4 13.5
A131 9 22.5
A141 9.8 24.5
A151 11.6 29
All  samples  of  aerogel  microspheres  were  soaked  in  solutions  containing  drug
molecules  to  entrap  drug  molecules  in  “nanoreservoirs”,  i.e. the  nanoporous  channels
comprising  meso  and  macropores.  Table  6.4  displays  the  adsorption  capacities  of  the
aspirin in aerogel microspheres. The result shows that alumino-siloxane aerogel samples
with smaller pore-diameter showed high loading of aspirin. Thus formulation suitable for
aspirin loading was A151. This result indicates that pore features play an important role in
influencing the adsorption amount of drugs on the surface.
6.2.2 Functionalization of alumino-siloxane aerogel
Since the active drug substances have different functional group, it is possible to
enhance their loading as well as the release rate by implementing special functional groups
on the surface of the drug carrier by means of functionalization. Hence, we have chosen
thiol (-SH) and amine (-NH2) bearing organofunctional silane for surface modification. The
aerogel  microsphere  A151 loaded  maximum  amount  of  drug  was  selected  for  surface
functionalization.  Amine  and thiol  functionalized samples  denoted as  A151  -1NH,  A151
-2NH, A151  -3NH and A151  -1SH, A151  -2SH, and A151  -3SH, respectively depending on
the amount of APTMS and MPTMS used for post grafing.
6.2.3 Characterization of functionalized aerogel microspheres 
SEM images of pure aerogel samples, amine and thiol functionalized samples are
given  in  Figure.  6.8.   According  to   SEM  images,   it   is   clear   that   all   samples
maintained  their  ordered  and  stable structure after functionalization  process.
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Figure 6.8 SEM of the alumino-siloxane aerogel microspheres (a)  A151,  (b) A 151-2NH,
and  (c)  A 151-2SH  
Table  6.5  also  lists  the  N2 adsorption/desorption  data  comprising  BET  and
Langmuir  surface  area,  pore  volume  and  pore  diameter  of  functionalized  aerogel
microspheres prepared by post synthesis (A 151-1NH, A 151-2NH, A 151-3NH, A 151-
1SH, A 151-2SH, and A 151-1SH ) together with the pure aerogel microspheres (A151), and
Figure 6.9 shows their isotherms. The pore size of functionalized aerogels is around 4-2nm,
which is smaller than that of A151, which has a pore size around 5.0nm. As expected, the
introduction of the organic moieties leads to a decrease in pore diameter, surface area and
pore volume, and this decrease is more noticeable for the matrix that contains the highest
amount of organic material. Furthermore, the marked reduction in pore size shows that the
pore wall is indeed decorated by organic moieties. The loss of surface area may be largely
attributed to the disappearance of these complementary smaller pores. The isotherms of
those  prepared  by post-synthesis  show a  very sharp  increasing  step with  a  typical  H1
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hysteresis loop Figure 6.9 corresponding to the highly ordered mesos/macrostructures and
narrow pore size distribution. 
Table 6.5 Physical characteristic of pure and functionalized aerogels alumino-siloxane
aerogel microspheres
Samples
BET /Langmuir
surface area (m2/g)
Total  pore
volume
(cm3/g)
Pore diameter
(nm)
A151 261/418 0.3124 5.0
A 151-1NH 213/394 0.2154 4.8
A 151-2NH 201/346 0.1450 3.5
A 151-3NH 184/294 0.0996 2.1
A151-1SH 236/404 0.2365 4.6
A151-2 SH 198/356 0.1235 3.4
A151-3SH 189/311 0.1023 2.0
MCM-41 985/1156 0.3254 2.8
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Figure 6.9 N2 adsorption–desorption isotherms of pure and functionalized alumino-
siloxane aerogel
Figure 6.10. Zeta potential of pure (A151) and functionalized (A151-2NH,  A151-2SH)
alumino-siloxane aerogel at different pH.
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We measured  the  zeta-potential  of  (A151)  and functionalized (A151-2NH,  A151-
2SH) alumino-siloxane aerogel at different pH in solutions with the pH ranging from 2 to
10 by automatic titration (Figure 6.10). The pH value of point of zero charge (PZC) for
A151,  A151-2NH, and A151-2SH are 6.8, 7.9 and 4.8 respectively.  The zeta potential of
A151-2SH microspheres shifted to negative region for wide range of pH, despite the acidic
nature of –SH groups form a negatively charged conjugate base on the surface aerogel
microspheres. In microspheres modified with APTMS, the zeta potentials shifted to more
positive values due to the presence of protonated amines (–NH+3). As a result, isoelectric
points of pH 6.8 shifted to pH 7.9 and pH 4.8 for,  A151-2NH, and A151-2SH modified
aerogel samples respectively, in agreement with literature reports[94] . 
Loading functionalized aerogel microspheres with aspirin.
To  evaluate  the  capability  of  the  functionalized  aerogel  microspheres  for  drug
delivery  system,  aspirin,  a  typical  anti  inflammatory  drug,  was  introduced  into
functionalized samples. The drug loading capacity of the aerogel samples were evaluated
and results are described in Table 6.6.  For comparison ordered porous MCM-41 was also
used. 
Table 6.6 Loading amount of aspirin on different aerogel microspheres.
Sample code
Concentrat
ion of drug
(mg/ml)
Amount of
Aspirin loaded
to 50 mg
microspheres
(mg)
Amount of
Aspirin loaded to
90 mg
microspheres
(mg)
%
Loading
Stock solution - - - -
A111 0.176 4.8 8.64 12
A121 0.173 5.4 9.72 13.5
A131 0.155 9 16.20 22.5
A141 0.151 9.8 17.64 24.5
A151 0.142 11.6 20.88 29
A 151-1NH 0.132 13.5 24.30 34
A 151-2NH 0.110 18 40.5 45
A 151-3NH 0.118 16.4 36.9 41
A151-1SH 0.089 22.2 39.96 55.5
A151-2SH 0.073 25.4 50.2 63.5
A151-3SH 0.092 21.6 38.8 54
MCM-41 0.142 10.4 18.72 27.5
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From the  drug  loading analysis  it  is  very clear  that  after  functionalization,  the
loading ability of aerogel microspheres is enhanced. Maximum drug loading is for samples
A151-2NH and A151-2SH. The following formulations were finalized by deriving the drug
loaded results.
 A 151-2NH, A151-2 SH and MCM-41
 The drug loading of  a maximum of 50 mg of  aspirin  was seen in  A151-2  SH
functionalized aerogel microsphere with a value of 50.2 mg which was loaded into 90mg
microspheres. The top three drug loaded aerogel samples were selected for the drug release
profile studies. Along with it MCM-41 which is regarded as ordered porous material was
also selected for comparative in-vitro release study.
The formulations with the drug loading less than 50 mg which is the minimum
dosage required were selected so as to study the release profile and if found favorable can
be utilized with a higher capsule size with more amount of microsphere.
From this the formulation A151-2 SH was selected and the capsule shells of size 1
were used for filling the aerogel microspheres.
Figure  6.11. shows  the  FTIR  spectra  of  aspirin  and  functionalized  A151-2SH  aerogel
microspheres  before  and after  loading aspirin.  After  loading aspirin,  the sample of  the
A151-2SH -aspirin shows a weak band at 1700 cm-1, which corresponds to the carboxylic
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group of aspirin. This indicated that part of the aspirin molecules interact with pore walls
through  hydrogen  bonding.  Two bands  at  1470  and  1380  cm-1 correspond to  the  C-H
bending vibration in the aspirin molecules. The band at 1760 cm-1 corresponding to COO-
groups of aspirin is still present on the spectrum, which also suggests that aspirin does not
degrade. Therefore, it further proves that aspirin has been loaded in the A151-2SH aerogel
microspheres.
6.3 Evaluation of Capsule 
Weight Variation Test
The aspirin loaded aerogel microspheres were filled in to capsule of size 1. Twenty
capsules were randomly selected and weighed to determine the average weight and were
compared with individual capsule weight. The percentage weight variation was calculated.
As per Indian Pharmacopoeial Specification, capsules with an average weight between 80 –
250 mg, the percentage deviation should not be more than ± 7. 5 % and capsules with an
average weight more than 250 mg should not be more than ± 10 %.
Table 6.7 Weight variation test for capsules
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The average weight  of  the 20 capsules was found to  be 210.3 mg.  The overall
percentile weight deviation is found within the limit as the pharmacopeial standards of ±
10%.
2. Drug Release - In-Vitro
The prepared formulations then placed in the shaker for the release studies over a
period of 24 hours. Since the formulation is a pH sensitive controlled drug release, the
release experiments were carried out at both acidic and basic pH in phosphate buffers of pH
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S.No:
Total
Weight of
Capsule
(mg)
Weight of
empty Shell
(mg)
Weight of
microsphere
(mg)
Weight of drug
loaded microspheres
(mg)
1 211 67 91 143
2 207 68 89 139
3 210 68 90 142
4 212 70 90 142
5 210 68 90 142
6 210 66 91 144
7 205 68 88 137
8 209 71 89 138
9 209 68 90 141
10 211 69 90 142
11 212 67 91 145
12 208 69 89 139
13 211 69 90 142
14 211 68 90 143
15 210 72 88 138
16 212 67 91 145
17 211 70 90 141
18 216 72 91 144
19 211 69 90 142
20 210 68 90 142
RESULTS AND DISCUSSION
2  and  pH  7.4.  The  results  showed  a  drastic  difference  in  the  release  pattern  while
comparing the nature of the physiological buffer solutions PBS.
Release Studies at Phosphate Buffer Solution (pH 7.4)
The release of the drug loaded aerogel  microspheres  which were functionalized
with a surface modification with A151-2 SH illustrated best release in controlled manner.
The release was estimated at 79.97 %. The release percentile of A151-2 NH functionalized
aerogels  was  found  to  be  lower  than  the  A151-2  SH with  69.41  %.  The  results  were
followed by the percentile drug release of 61.17 for the formulation A151. When compared
to the multiporous aerogel microspheres MCM-41 showed abrupt release.
Table 6.8 In Vitro Release of A151-2 SH
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Figure 6.12. Cumulative % drug release of A151-2SH
Table 6.9 In Vitro Release of A151-2 NH
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Time (hr) % Drug release Cumulative % Drug release 
0.5 36.19 36.19 
1 49.10 50.19 
2 64.02 64.2 
8 77.89 78.01 
12 78.51 78.63 
24 79.88 79.97 
RESULTS AND DISCUSSION
Figure 6.13. Cumulative % drug release of A151-2NH
Table 6.10. In Vitro Release of 4A
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Time(hr) % Drug release Cumulative % drug release
0.5 31.3 31.3
1 44.45 44.5
2 56.38 56.45
8 67.49 67.54
12 67.88 67.97
24 69.31 69.41
RESULTS AND DISCUSSION
Figure 6.14. Cumulative % drug release of 4A
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Time(hr) % Drug Relaese Cumulative % drug release
0.5 31.76 31.86
1 41.69 41.78
2 52.88 53.1
8 59.11 59.2
12 59.61 59.77
24 61.06 61.17
RESULTS AND DISCUSSION
Table 6.11 In vitro release of MCM- 41
Figure 6.15. Cumulative % drug release of MCM-41
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Time (hr) % Drug release Cumulative % Drug release
0.5 52.51 52.51
1 53.42 53.51
2 53.51 53.52
8 53.77 53.88
12 54.18 54.26
24 56.41 56.49
RESULTS AND DISCUSSION
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Figure 6.16. Cumulative % drug release collective graph at pH 7.4
RESULTS AT PHOSPHATE BUFFER SOLUTION (pH 2)
The  drug  release  was  studied  in  phosphate  buffer  of  pH  2.  The  release  was
examined to show the release rates were well below 20 percent for all the formulations.
The amount of drug release   trend inverts for the groups carrying A151-2SH and A151-
2NH.
The inversion in  the trend is  due to  change in  the  surface  charge  .This  can be
explained as these pH sensitive microspheres the drug molecule which does not dissociate
from the drug. The percentage  of drug release profile was seen to be highest amongst them
in A151-2NH which stands at 15.8%, followed by the A151-2SH value of 13.8%.
The ordered porous MCM-41 was seen to have a lesser release 11.2% which is
least.
K. M. COLLEGE OF PHARMACY, MADURAI Page 92
RESULTS AND DISCUSSION
0 5 10 15 20 25
0
10
20
30
40
50
60
70
80
C
u
m
u
l
a
t
i
v
e
 
%
 
d
r
u
g
 
r
e
l
e
a
s
e
Time (hr)
 A 15
1
-2NH
 A15
1
-2SH
 A15
1
 MCM-41
Fig 6.17. Cumulative % drug release at pH 2
Optical images of alumino-siloxane aerogel microsphere
Fig 6.18. Optical microscopy images of aspirin loaded microspheres
Optical images were obtained and the spherical aerogel beads seen with the loaded
drug. The images shows the spherical nature of these sphere when observed under high
resolution.
K. M. COLLEGE OF PHARMACY, MADURAI Page 93
RESULTS AND DISCUSSION
Optical images of alumino-siloxane aerogel microsphere filled in capsules
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6. CONCLUSION
The  work  focused  on  the  synthesis  of  new drug  carrier  for  those  drugs  which
require controlled drug release. The synthesis of this novel carrier brings with it a great
hope in future as a potential carrier. The alumino siloxane aerogel microspheres showed
both promising drug loading and drug release for which the results were confirmed. The
functionalized  inorganic  multiporous  channels  act  as  the  suitable  candidate  for  the  pH
sensitive drug delivery. The drug would be released in the intestinal pH of 7.4 only. The
results  obtained  proved  that  aerogels  acts  as  a  best  candidate  for  the  controlled  drug
delivery; releasing the drug in the required fashion there by increasing the bioavailability of
the drug. 
Only since the past half a decade the researchers have realized the importance of
aerogels in the field on pharmaceutical industry before which its main application was as in
insulator in packaging materials. Exploration has been done on silica and funtionalization;
but this work was carried out on organically modified alumina silicate which is  a step
ahead
The technique would be highly cost effective since no binders and enteric coating
polymers need to be used. The number of excipients used for the formulation is also very
low. This in turn is a novel approach a face changer for most of the drugs.
This  work  is  being  extended  for  studying  the  biocompatibility  of  the  aerogel
microbeads.  And  it  is  planned  to  conduct  the  experiments  on  the  rat  model  as  a
pharmacological evaluation.
 Research has to extend to the next level to see this type of dosage form in the
market. 
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